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 ABSTRACT 
Effect of Time of PGF2α Application on Reproductive Outcome in Ewes 
 
Callayn Danae Paul 
 Traditionally, prostaglandin F2α (PGF2α) has been included in short-term 
progesterone-based estrous synchronization (STPBES) protocols but its inclusion has 
been associated with a reduction in fertility at the synchronized estrus.  Also, previous 
studies have shown that there are differences in the endocrine status and follicular 
dynamics of ewes at different stages of the estrous cycle, although effects have not been 
sufficiently evaluated regarding the reproductive outcomes when luteolysis is induced on 
different days of the cycle.  To evaluate the effect of time of application of PGF2α relative 
to the progesterone treatment on fertility, ewes (N=442) from 4 farms located in WV and 
PA were randomly assigned to receive controlled internal drug-releasing devices (CIDR-
g; 0.3 g progesterone) for 5 days alone (n=123; treatment 1), in combination with 25 mg 
PGF2α (5 mL Lutalyse; Dinoprost Tromethamine; Zoetis) at CIDR insertion (n=103; 
treatment 2) or removal (n=100; treatment 3), or 25 mg PGF2α alone (n=116; treatment 4) 
prior to being joined with sexually mature rams.  To compare reproductive performance 
in ewes treated with PGF2α at different stages of the estrous cycle, ewes (N=148) from 1 
farm located in southwestern PA were pre-synchronized using treatment with a CIDR 
device for 7 days.  Ewes were randomly assigned to receive a 25 mg intramuscular 
injection of PGF2α 7 (n=48), 10 (n=50), or 13 (n=50) days following CIDR removal 
which was projected to be equivalent to day 5, 8, and 11 of the estrous cycle.  Ewes were 
then joined with sexually mature rams on the day of PGF2α injection.  Data were analyzed 
using analysis of variance with the model consisting of the main effects of treatments, 
farms and their interactions and additionally, least square means for treatment effects 
were determined.  Estrous response did not differ among ewes receiving progesterone-
based treatments but was significantly lower in ewes receiving PGF2α only.  Pregnancy 
rate to first service was highest in ewes receiving CIDR only.  The percent of ewes 
lambing to first service was greater in ewes treated with CIDR only than in ewes treated 
with PGF2α (p=0.05).  In experiment 2, the mean estrous response was 85.1% and did not 
differ with treatment.  Conception rate was higher in ewes treated with PGF2α at predicted 
day 5 than those injected at day 11 (p<0.05) and tended to be higher than ewes injected 
on day 8 (p<0.1).  Pregnancy rate to first service tended to be higher in day 5 than day 11 
ewes (p=0.07), and more ewes lambed to first service when treated at day 5 than at either 
day 8 or 11 (p=0.05).  First service prolificacy was also greater in ewes treated at 
predicted day 5 than those injected on day 11 (p=0.05) and tended to be higher than that 
of ewes injected with PGF2α at predicted day 8 (p=0.14).  In conclusion, application of 
PGF2α at the beginning or end of progesterone pretreatment did not enhance synchrony of 
estrus or other reproductive outcomes and synchronization of estrus with a 5 day 
treatment with progesterone was sufficient to synchronize estrus with higher fertility.  
Additionally, application of PGF2α earlier in the estrous cycle resulted in improved 
reproductive performance. 
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REVIEW OF LITERATURE 
I.  Estrous Synchronization 
Estrous synchronization is an important component for optimization of livestock 
reproductive management that has been used commonly since the 1940’s (Abecia et al., 
2011).  The operative goal of an efficient estrous synchronization program is to have a 
simple, cost-effective method to produce offspring at a desired timepoint, either through 
natural service or artificial insemination, in order to maximize farm profitability.  
Synchronization or induction of estrus is utilized to time as well as to synchronize mating 
and parturition in the ewe as well as the time of weaning of lambs.  Synchronization of 
estrus can also be used to decrease unproductive intervals and provide a more continuous 
supply of lamb (Carlson et al., 1989; Contreras-Solis et al., 2009).  The outcomes from 
estrous synchronization include better assignment of labor, reduction in neonatal 
mortality, and improved strategic marketing of lambs leading to increased production and 
profitability.  Weaning of offspring that are born at a similar timepoint also leads to more 
uniform lamb crop for market and allows scheduling of lambing at times that are 
advantageous in terms of supplies, labor, facilities, and market price trends (Carlson et 
al., 1989).  Synchronization of estrus also allows for optimization of efficiency of 
producers’ time and facilities by shortening the span of lambing ewes, whereby reduction 
of lamb mortality can also be achieved with greater observation of lambs during their first 
three days of life when mortality is highest (Knights et al., 2003). 
With the continuous decline in the sheep industry over the past several years, an 
increase in reproductive efficiency could reduce the cost of lamb and help revive the state 
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of the industry (Knights et al., 2003).  Use of reproductive technologies to synchronize 
estrus in ewes can also allow the producer to select a time at which to breed a higher 
number of ewes so the time of lambing can be pre-determined.  Ewes whose estrus 
periods are synchronized lamb at a time that is more convenient to the producer, and 
additionally those lambs can be sold at pre-defined marketing periods.  Application of 
these techniques also serves to shorten the duration of lambing, which saves the producer 
both time and money with greater efficiency of their lambing system.  Additionally, 
because sheep are seasonal breeders, there is a seasonal pattern of production for meat 
and milk, so ewes that are bred to have their lambs weaned at a time when the seasonal 
supply is low have the potential to garner higher market prices for meat (Abecia et al., 
2011). 
A number of beneficial assisted reproductive technologies rely on the utilization 
of estrous synchronization methods to synchronize components of the estrous cycle of 
female animals.  Artificial insemination (AI) is one such application that is made more 
feasible through estrous synchronization (Fierro et al., 2011).  Traditionally, it had been 
impractical to accomplish in sheep due to difficulty of detecting estrus, but with more 
efficient methods of synchronizing estrus, AI has become a more successful and 
commonplace practice in sheep (Abecia et al., 2011).  Artificial insemination is an 
important tool to allow for genetic improvement and diversity in a flock (Amiridis et al., 
2012).  Superovulation and embryo transfer have additionally become more 
commonplace with the utilization of a pre-synchronized estrus in order to maximize the 
number of offspring produced by a genetically desirable female or to produce superior 
males as semen donors for AI (Abecia et al., 2011; Amiridis et al., 2012).  Effective 
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estrous synchronization methods make use of these technologies feasible, and thereby 
help facilitate genetic improvement and reproductive efficiency in flocks. 
II.  Ovine Estrous Cycle 
 The development and use of cost effective estrous synchronization programs are 
based on a comprehensive knowledge of the ovine estrous cycle.  Sheep are seasonally 
polyestrous and have an estrous cycle that averages 16-18 days in length (Bartlewski et 
al., 2011).  The primary environmental determinant of annual cyclicity is photoperiod but 
factors such as temperature, nutritional status, social interactions, and lactation period are 
known to modulate it (Rosa et al., 2003).  Ewes typically transition into an estrous state 
beginning in late summer or early autumn in response to shortening day length, which is 
perceived by the pineal gland through the retina (Abecia et al., 2011). 
The pineal gland is responsible for synthesizing and secreting melatonin 
nocturnally, so its secretion is inversely related with daylength (Malpaux et al., 1996).  
Melatonin is involved with regulation of secretion of gonadotropin releasing hormone 
(GnRH) from the hypothalamus via a multistep neural pathway.  An increase in duration 
of melatonin secretion resulting from a decrease in daylength then leads to an increase in 
secretion of GnRH from the hypothalamus (Abecia et al., 2011).  GnRH induces the 
release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the 
anterior pituitary gland (Rosa et al., 2003).  LH and FSH are also called gonadotropins 
because they then act on the ovaries, or gonads, of the female to stimulate follicular 
growth and development (Abecia et al., 2011). 
Sheep typically have 2-4 waves of antral follicular emergence per estrous cycle 
regulated by progesterone and gonadotropins and the final as well as the penultimate 
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wave yields the ovulatory follicle(s) in a state of weak follicular dominance (Bartlewski 
et al., 2011; Leyva et al., 1998; Evans et al., 1999).  In ewes, ovulable follicles are 
present throughout the estrous cycle (Houghton et al., 1995).  As the follicles grow and 
mature, they secrete increasing amounts of estrogen (Bartlewski et al., 2011).  Estrogen 
exerts ovarian control on the hypothalamus via both positive and negative feedback 
mechanisms depending on its circulating concentration (Senger, 2012).  During follicular 
development, it stimulates the hypothalamus to secrete GnRH and subsequently the 
anterior pituitary gland to secrete LH (Karsch et al., 1993).  Once the pulsatile release of 
LH reaches a threshold amplitude and frequency, ovulation occurs 24-27 hours later 
(Bartlewski et al., 2011; Inskeep, 2005; Rubianes et al., 2003). 
During ovulation, the follicle ruptures and the oocyte is expelled, which leaves a 
remnant of the follicle on the ovary.  LH acts on both the thecal and granulosal cells of 
the follicular remnant to form the small and large cells of the corpus luteum (CL) 
respectively through a process called luteinization (Weems et al., 2006).  The CL is a 
transient endocrine gland that synthesizes and secretes increasing amounts of 
progesterone as it reaches structural and functional maturity (Bartlewski et al., 2011).  
Progesterone has an inhibitory effect on the hypothalamus and suppresses the release of 
GnRH, which subsequently leads to a reduction in output of LH and FSH by the anterior 
pituitary gland (Senger, 2012).  In the absence of fertilization, uterine PGF2α is released 
in increasing amounts 11-12 days following estrus, which induces luteal regression and 
therefore a decline in progesterone concentration (Baird et al., 1976; Ottobre et al., 1984; 
Inskeep, 2005). Uterine release of PGF2α is negligible prior to this timepoint, and it has 
been established that luteolysis in sheep involves a local feedback loop between the 
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uterus and the corpus luteum (Baird et al., 1976; Scaramuzzi et al., 1977; Wiltbank and 
Casida, 1956).  Also, structural luteolysis is an irreversible process (Baird et al., 1976). 
This process has been shown to be regulated by a high concentration of 
progesterone, which is important for timing the initial peaks of PGF2α (Vincent and 
Inskeep, 1986).  The decreasing concentration of progesterone also modulates the release 
of PGF2α from the uterus by keeping it at midrange values until luteolysis has begun, 
where with decreasing concentrations, greater amounts of PGF2α are released from the 
uterine endometrium to complete the regression of corpora lutea (Vincent and Inskeep, 
1986; Griffeth et al., 2002).  The inhibitory effect of progesterone is then removed and 
estrus and ovulation can ensue to initiate a new cycle during which the ewe will have 
another opportunity to become pregnant. 
 The estrous cycle is divided roughly into two phases:  the follicular and luteal 
phases.  The follicular phase lasts for 2-4 days and is characterized by a predomination of 
circulating estrogen, which leads to behavioral estrus followed by a surge in luteinizing 
hormone and subsequently ovulation (Inskeep, 2005).  The luteal phase lasts for 12-14 
days in the ewe and can be defined as the length of time during which one or more 
corpora lutea are present on an ovary.  This phase is characterized by a high circulating 
concentration of progesterone, which is released by the corpus luteum that is formed from 
the post-ovulatory follicular remnant (Knights et al., 2003).  As the primary component in 
defining the length of the estrous cycle, manipulation of the luteal phase length is the 
most common mode of estrous synchronization.  Additionally, a thorough understanding 
of the mechanics and endocrine variables during these two phases is important for 
manipulating said variables for estrous synchronization. 
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III.  General Approaches to Synchronization of Estrus 
 Since the 1940’s, a number of different methods for synchronizing the 
estrous cycle in ewes have been used and can include either natural or artificial/hormonal 
treatments to impact the cycle (Abecia et al., 2011).  Commonly, exogenous hormones 
such as progesterone and prostaglandin F2α (PGF2α) or their synthetic analogues are used 
both exclusively as well as in combination to modify the physiologic duration of natural 
hormonal events to alter the luteal phase of the estrous cycle.  Although there are 
numerous different methods that can be utilized to control the estrous cycle, two main 
approaches have traditionally been used.  One involves utilizing PGF2α or its analogues to 
eliminate endogenous progesterone and the other uses exogenous progesterone or 
progestogens. 
The main concepts involved in their use are that progestagens exert their effect 
primarily through mimicking the activity of the corpus luteum in order to extend or enact 
an artificial luteal phase by suppressing circulating LH and ovulation until the CL is 
regressed or the exogenous source of progesterone has been removed or the progesterone 
has been metabolized by the ewe.  PGF2α shortens the treated luteal phase by regressing 
the corpus luteum prematurely so that ewes transition into proestrus and estrus together 
(Karsch et al, 1977).  Progesterone-based approaches are generally preferred by 
producers over prostaglandin-based protocols, as the fertility obtained from a particular 
synchronization approach often determines its feasibility (Fierro et al., 2013; Greyling 
and Brink, 1987).  Typical estrus synchronization rates associated with prostaglandin-
based (Gonzalez-Bulnes et al., 2002; Godfrey et al., 1997) and progestagen-based 
protocols (Langford et al., 1983; Simonetti et al., 2000) are approximately 70% and 80% 
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respectively.  During the breeding season, each method can be used either alone or in 
combination with the other and both hormones modify the natural estrous cycle by 
altering the length of the luteal phase. 
i. Progesterone-Based Approaches 
The use of progesterone in control of the ovine estrous cycle was first reported in 
1948 to be an effective method to synchronize estrus and ovulation in ewes that were at 
three different points of cyclicity (Dutt and Casida, 1948).  Initially, only long-term 
progesterone treatments were utilized in sheep, which lasted for 12-14 days or longer 
(Dutt and Casida; 1948; O’Mary et al., 1950; Robinson, 1964; Gordon, 1975; Allison, 
1978).  The length of treatment with progesterone was likely maintained for such a 
duration based on the assumption that progestational treatment must span the length of 
the natural ovine luteal phase in order to ensure absence of luteal tissue at cessation of 
treatment (Dutt and Casida; 1948, Woody et al., 1967).  Such methods were long-lasting 
and often resulted in lower fertility. 
Several methods of administering progesterone or its synthetic analogues 
(progestogens) have been developed.  Progestogens have been delivered through 
inclusion in the feed as melengestrol acetate (MGA), implants under the skin 
(Norgestomet-SynchroMate B), intravaginal sponges containing flurogestone acetate 
(FGA) or medroxyprogesterone acetate (MAP), and intramuscular injections (Knights et 
al., 2003; Gordon, 1975; Gordon, 1977).  Limiting factors of delivery devices have been 
their capability to maintain high concentrations of progesterone in the ewe throughout the 
treatment period, to be retained properly within the animal, and to be delivered in a 
sanitary manner as hygienically as possible.  
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Although initially administered via injections, progestational agents have been 
utilized through intravaginal devices since the ‘60s through intravaginal sponges 
(Robinson, 1964; Robinson, 1965) and more currently, controlled internal drug releasing 
(CIDR) devices (Welch et al., 1984; Wheaton et al., 1993).  Intravaginal devices allow 
for an abrupt cessation of hormonal treatment (Abecia et al., 2011).  The CIDR was 
developed in New Zealand by Dr. Welch and Dr. Miller in 1984 and is made of a 
progesterone-impregnated silicone elastomer molded over a nylon core (Welch, 1984).  
CIDR devices provide high circulating levels of natural progesterone with a loaded 
dosage of 0.30 grams (Abecia et al., 2011; Welch et al., 1984; Carlson et al., 1989), are a 
more sanitary intravaginal device in comparison with sponges, and neither impede nor 
absorb vaginal secretions (Welch, 1984; Carlson et al., 1989; Wheaton et al., 1993).  It 
has also been shown to provide mean progesterone concentrations approximately twice 
that of implants and sponges so it is an effective mode of administering high doses of 
exogenous progesterone (Hamra et al., 1986). 
 The mean plasma progesterone content has been observed to rise to peak values 
of 5.5 ng/ml within two hours of CIDR insertion in ovariectomized ewes, a level of 
which exceeds the typical mid-luteal plasma concentration of approximately 3 ng/ml, 
suggesting that it is rapidly released and absorbed effectively through the vaginal wall 
(Ainsworth and Downey, 1986; Carlson et al., 1989).  Additionally, the plasma 
progesterone concentration returned to basal values within four (Ainsworth and Downey, 
1986) to six (Greyling and Brink, 1987) hours of CIDR device removal.  Results from 
prior experiments have shown that progesterone can drift into and out of muscle tissue 
rapidly, and is maintained at similarly equal concentrations between muscle, fat, and 
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plasma (Kincl, 1971; Carlson et al., 1989).  This is of importance as abrupt cessation of 
progesterone exposure is an important feature of reproductive management technologies 
and it illustrates that progesterone originating from CIDR devices is cleared rapidly and 
residues in meat should not be of concern to consumers of lamb or mutton. 
1) Long-Term Progesterone-Based Synchronization Protocols 
 Traditionally, long-term treatments of progestogens have been utilized in order to 
synchronize estrus in ewes (Dutt and Casida, 1948, Robinson, 1965).  Progestogens have 
generally produced more favorable estrous response in comparison with prostaglandin-
based protocols (Gonzalez-Bulnes et al., 2002; Godfrey et al., 1997; Langford et al., 
1983; Simonetti et al., 2000).  However, use of progestogens in estrous synchronization 
can be associated with a degree of sub-fertility compared with the unaltered cycle due to 
alterations in the pattern of LH release (Scaramuzzi et al., 1988; Haresign, 1985; Letelier 
et al., 2011) and decreases in sperm transport and survival in the reproductive tract 
(Hawk and Conley, 1971).  One factor that could help elucidate the disparity in fertility 
often noted between the two approaches could be the increased uterine vascularity 
observed in progestogen-treated compared with prostaglandin-treated ewes.  A study 
recently conducted by Ruiz-Gonzalez et al. compared the effects on caruncular early 
angiogenesis between the two approaches and found a higher number of capillary vessels 
and vascular endothelial growth factor (VEGF) in progestagen-treated ewes and evidence 
of impaired vascular development and remodeling of caruncular tissue in prostaglandin-
treated ewes (Ruiz-Gonzalez et al., 2013). 
Whereas some studies have found long-term progesterone treatments to result in 
fertility comparable with that of spontaneous breeding during the natural breeding season 
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with an overall lambing percentage of approximately 90-95% (Carlson et al., 1989), other 
studies have found a reduction in fertility despite a high incidence of ewes showing estrus 
(Vinoles et al., 2001; Robinson et al., 1970).  This decrease in conception rate has been 
attributed to the modified hormonal milieu leading to asynchrony between estrus and 
ovulation (Scaramuzzi et al., 1988).  Additionally, reduction in fertility at the 
synchronized estrus following treatment with MAP for 12-14 days might be due to 
steroid effects on follicular development (Kruip and Brand, 1975).  Long-term 
progestogen treatments could be associated with a lower circulating concentration of 
progesterone, as the progesterone concentration decreases continually after day 3 in ewes 
treated with a single CIDR-g (Wheaton et al., 1993).  Subluteal progesterone 
concentrations have been observed to result in persistent follicles in the majority of ewes 
studied (Johnson et al., 1996), and extension of the first wave dominant follicle’s lifespan 
in turn delays emergence of the following follicular wave (Vinoles et al., 1999). 
Decreased conception rates (72 vs. 98%) have also been observed in ewes treated 
with a subluteal concentration of progesterone in comparison with control ewes (Johnson 
et al., 1996), whereas ewes treated with supraluteal concentrations have shown a decrease 
in the growth of the dominant follicle (Rubianes et al., 1997) as well as increased 
follicular turnover (Noel et al., 1994).  Higher pregnancy rates observed with short term 
versus long-term progesterone treatment have been related to more rapid follicular 
turnover (Vinoles et al., 2001).  It appears then that the degree of follicular senescence 
and its effects on fertility may shift in relation to dosages of progestogens or duration of 
treatment.  Long-term progestogen treatments have also been implicated in a reduction in 
the number of total follicles and impaired overall viability of embryos (Gonzalez-Bulnes 
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et al., 2005) but have produced a high degree of synchrony (Vinoles et al., 2001).  
Although progestogen-based protocols have generally been preferred by technicians over 
prostaglandin-based techniques, the poor fertility often associated with long-term 
treatments as well as the long duration of time required for their use have made long-term 
treatments’ practical use less than ideal.  
2) Short-Term Progesterone + Prostaglandin Combination Protocols 
 More recently, short-term progesterone-based estrous synchronization protocols 
have been shown to be a successful alternative to long-term treatments (Vinoles et al., 
2001; Dixon et al., 2006).  Short-term progesterone treatments of approximately 5-7 days 
block ovulation until the source of progesterone is removed, but may not allow sufficient 
time for corpora lutea to mature fully (Beck et al., 1993).  Therefore, these treatments 
have been used in combination with PGF2α in order to shorten the treatment period from 
that of long-term CIDR use as well as to avoid the issue of ewes with corpora lutea that 
are refractory to PGF2α, as may be encountered using single PGF2α injection regimens 
(Beck et al., 1993).  These approaches have been shown to produce comparable and often 
improved fertility in comparison with longer duration progestagen treatments (Fitzgerald 
et al., 1985; Ozturkler et al., 2003) as well as prostaglandin-based protocols (Dixon et al., 
2006; Beck et al., 1993; Loubser and Van Niekerk, 1981).  Combination treatments are 
effective due to the fact that the progesterone pretreatment prevents formation of corpora 
lutea for the duration of treatment, and therefore ensures that any existing corpora lutea 
are a minimum of five days old and therefore sensitive to prostaglandin administration 
(Acritopoulou et al., 1980; Beck et al., 1993).  When prostaglandin is injected at 
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progestogen removal, all individuals should undergo luteolysis simultaneously (Beck et 
al., 1993). 
 The combination protocol reduces the exposure of animals to intravaginal devices 
and provides a reduction in duration of progestagen pretreatment (Abecia et al., 2011).  
The length of progestagen treatment has been reduced from 8-9 days in earlier 
experiments (Greyling et al., 1979; Loubser et al., 1981) to 5-7 days in more recent 
studies in sheep (Fitzgerald et al., 1985; Beck et al., 1993; Ozturkler et al., 2003; Dixon et 
al., 2006).   Overall, these short-term treatments have produced a high estrus response 
with 80 (Ozturkler et al., 2003), 82 (Dixon et al., 2006), 89 (Fitzgerald et al., 1985), and 
100 percent (Beck et al., 1993) and conception rates of 76-93 percent (Loubser et al., 
1981; Ozturkler et al., 2003; Fitzgerald et al., 1985; Dixon et al., 2006).  This method has 
also been demonstrated to be an effective mode of estrous synchronization both in cattle 
(Beal, 1983; Smith et al., 1984) as well as goats (Corteel et al., 1988; Kusina et al., 2000).  
However, despite producing a high degree of synchrony, combined treatments of PGF2α 
and progesterone present an approximately 30% higher cost in comparison with treatment 
of exogenous progesterone alone. 
3) Short-Term Progesterone Treatment without PGF2α 
Few studies have evaluated the use of short-term progesterone-based protocols 
without the use of prostaglandin.  However, there is some evidence that suggests that 
inclusion of PGF2α may not be necessary.  Higher pregnancy rates have been observed in 
ewes using 6 day (87%) than 12 day (63%) progestogen treatments, both without the use 
of prostaglandin (Vinoles et al., 2001).  Slower follicular turnover associated with long-
term treatments can induce ovulation of persistent dominant follicles, and it was proposed 
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that the higher pregnancy rate associated with the short-term treatment may be attributed 
to the ovulation of newly recruited growing follicles (Vinoles et al., 2001).  This was 
supported by the observation that the ovulatory follicle emerged prior to sponge 
withdrawal in ewes treated with long-term progesterone and around the time of sponge 
removal in the short-term treatment ewes (Vinoles et al., 2001). 
Short term progesterone treatment can provide a higher circulating concentration 
of progesterone in comparison with long-term treatments, as the highest concentration 
with CIDR use is reached on day 3 and decreases thereafter (Wheaton et al., 1993).  Prior 
research has illustrated that the dose of exogenous progesterone administered was 
positively related with the number of ewes exhibiting estrus and lambing (Robinson et 
al., 1968; Allison and Robinson, 1970).  This data is of practical benefit to meeting 
producers’ objectives of utilizing cost-effective and efficient method of reproductive 
management, as it provides a means of estrous synchronization that does not require a 
long period of preparation, needs no other exogenous hormones to aid in supporting a 
fertile outcome, and is 30% cheaper than combination treatments. 
ii. Prostaglandin-Based Approaches 
 Prostaglandin-based estrous synchronization protocols involve the termination of 
the luteal phase of the ewe by regressing corpora lutea.  Prostaglandin F2α is the primary 
luteolytic hormone in sheep (McCracken et al., 1970; McCracken et al., 1972; Barrett et 
al., 1971; Light et al., 1994) that is produced by the non-pregnant uterine endometrial 
glands (Scaramuzzi et al., 1984).  PGF2α is metabolized at an extremely rapid rate; for 
example, 99% of injected PGF2α is metabolized through a single pulmonary passage to 
15-keto-PGF2α and 13,14-dihydro-15-keto-PGF2α (Davis et al., 1980; Piper et al., 1970).  
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The minimal exogenous dose that has been shown to induce luteolysis in sheep is 
approximately 2 ug/hour (Chamley et al., 1972).  High doses are required in systemic or 
intramuscular administration in order to be effective, with higher doses of 20-24 mg 
producing greater estrous response (Scaramuzzi et al., 1984; Fukui and Roberts, 1981; 
Hackett and Robinson, 1980).    It has been well-established that the effectiveness of 
prostaglandin (measured through the proportion of ewes detected in estrus) is dose-
dependent, with ewes having more recently formed corpora lutea requiring a higher 
luteolytic dose of PGF2α (Fierro et al., 2013; Pope et al., 2004; Loubser et al., 1981; 
Hackett et al., 1980), but another study found that lower doses to be sufficiently effective 
using more potent analogues of PGF2α (Contreras-Solis et al., 2009).  Additionally, the 
luteolytic efficacy of prostaglandin is day, frequency of exposure, and route dependent 
(Pope et al., 2004; Douglas and Ginther, 1973). 
The effectiveness of prostaglandin-based approaches is limited to ewes with a 
mature, active corpus luteum a minimum of 3-5 days old for their efficacy in luteolysis 
(Hackett et al., 1980; Rubianes et al., 2003; Pope et al., 2004).  The refractoriness of 
newly formed corpora lutea is restricted to the first two days (Rubianes et al., 2003), and 
has been shown to be associated with strong luteal catabolism of PGF2α by 15-
hydroxyprostaglandin dehydrogenase (PGDH); (Silva et al., 2000).  Early corpora lutea 
(day 4) have been found to have increased intraluteal enzymatic activity of PGDH 
converting PGF2α to 13,14-dihydro-15-keto- PGF2α (PGFM) in comparison with older 
(day 13) corpora lutea (Silva et al., 2000; Hansen, 1974; Ensor and Tai, 1995).  This in 
turn could prevent uterine PGF2α from gaining access to receptors on large luteal cells 
and transiently prevent luteolysis (Silva et al., 2000). 
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When a single injection is applied to a flock of randomly cycling ewes, only 66% 
of ewes are expected to respond because the corpus luteum of the ewe is only responsive 
to prostaglandin F2α between days 4-14 of the estrous cycle (Acritopoulou and Haresign, 
1980).  Ewes that are either in the follicular or early or late luteal phase will be 
unresponsive to its effect (Pope et al., 2004; Trounson et al., 1976).  Whereas most 
studies have found a general reduction in fertility associated with prostaglandin use, some 
studies have found no differences when comparing long-term (12 day) progestagen-
impregnated sponge use in comparison with an 11 day double injection regimen of PGF2α 
(Hackett et al., 1981; Allison et al., 1978). 
Although treatment with a single injection of PGF2α could produce a high degree 
of synchrony if all ewes treated are in the luteal phase at the time of injection 
(Acritopoulou et al., 1977), this is often an unrealistic situation when attempting to 
synchronize estrus in a flock of randomly cycling ewes.  The problem of ewes being 
refractory to the effect of PGF2α  due to treatment at stages of their estrous cycle in which 
they do not have a CL that is sensitive to exogenous prostaglandin can be avoided by 
providing two injections of PGF2α 9-12 days apart (Loubser et al., 1981; Acritopoulou et 
al., 1978; Allison et al., 1978).  This ensures that all ewes should be in the mid-luteal 
phase at the time of the second injection, but fertility will often still be reduced due to 
poor final maturation of preovulatory follicles from reduced LH (Barrett et al., 2002). 
A comparison study of two commonly used prostaglandin-based protocols has 
produced estrus response and conception rates of 97% and 80% respectively for the 11 
day double injection regimen in comparison with a 73% estrus response and 64% 
conception rate with a single injection utilizing 20 mg of PGF2α (Beck et al., 1987).  
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However, other experiments have resulted in poor fertility using double injection 
protocols.  One study found that only 45% of ewes administered a prostaglandin analogue 
(ICI-80,996) had ovulated by 70 hours following treatment in comparison with 90% 
treated with a progestogen (SC-9880) and of ewes that had ovulated, the progestogen-
treated ewes had a significantly higher fertilization rate (69% vs. 7%) (Boland et al., 
1978). 
A number of factors could help explain the variable fertility often observed with 
prostaglandin-based synchronization methods.  Prostaglandin-based protocols have been 
shown to alter sperm transport in the reproductive tract (Hawk and Cooper, 1977).  
Follicles induced to ovulate with prostaglandin F2α have been observed to contain fewer 
granulosa cells and have resulted in a longer estrous cycle (Wiley et al., 1997).  
Synchronization of estrus with prostaglandin results in preovulatory follicles with altered 
steroidogenic capacity which produce subfunctional corpora lutea (White et al., 1987; 
Wiley et al., 1997; Letelier et al., 2011).  Additionally, steroids are essential for 
preparation of the reproductive tract for fertilization and embryo transport and also serve 
to induce appropriate myometrial contractions for improvement of fertility (Fierro et al., 
2011; Meikle et al., 2001; Sosa et al., 2008).  Overall, these factors could help explain the 
reduction in fertility associated with the use of prostaglandin-based protocols in 
comparison with progesterone-based treatments. 
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IV. Effects of Application of Synthetic Progestogens on Components of the Estrous 
Cycle 
 i. Effect on Ovulation 
 Traditional progesterone-based synchronization protocols involved the use of 
progesterone or, more commonly, its analogues for durations that met or exceeded the 
length of the natural luteal phase of the ewe, which normally lasts 12-14 days and is the 
longest component of the estrous cycle (Dutt and Casida, 1948).  This ensures that any 
existing corpora lutea in treated ewes would have sufficient time to undergo luteolysis by 
the time of removal of the progestogen source.  Additionally, progesterone inhibits the 
secretion of GnRH and LH secretion so ovulation is blocked until progesterone decreases 
and its inhibitory effect on the release of LH is lost (McLeod et al., 1984; Amiridis et al., 
2012).  In conclusion, long-term progestogen treatment serves to mimic the corpus 
luteum to provide an artificial luteal phase for a period of time that would allow natural 
luteolysis to occur until progestational treatment ceases while blocking new ovulations. 
ii. Effect on Synthesis/Secretion of PGF and Duration of the Estrous Cycle 
The possibility for the potential effectiveness of short-term treatments was first 
proposed in 1967 that adequate synchronization could be accomplished by administering 
progesterone for a duration shorter than the natural lifespan of the CL (Woody et al., 
1967).  This was based on the observation that progesterone injected during the early 
luteal phase would induce premature luteal regression, thereby shortening the length of 
the cycle (Woody et al., 1967).  It has been well established that progesterone plays a 
significant role in determining the length of the estrous cycle through establishing the 
timing of the release of PGF2α (Ottobre et al., 1980; Silvia et al., 1991; Mann et al., 
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2001).  It is known that progesterone is responsible for potentiating the endometrium to 
secrete PGF2α and regulating the timing of initial releases of PGF2α for luteolysis as well 
as modulating its episodic release (Inskeep, 2005).  Decreasing concentrations of 
progesterone induce a greater secretion of PGF2α by the endometrium for the completion 
of luteolysis to occur, and maximal secretion of PGF2α is released after luteal regression 
has occurred (Griffeth et al., 2002). 
Although both progesterone as well as estrogen are known to play major roles in 
controlling the development of endometrial oxytocin receptors and PGF2α release, 
treatment with progesterone alone has been demonstrated to be sufficient to induce 
responsiveness to oxytocin, as measured by release of PGF2α (Homanics et al., 1988; 
Vallet et al., 1990).  This has been demonstrated through the use of steroid-treated 
ovariectomized ewes and cows (Mann et al., 2001).  However, endometrial receptor 
numbers decline by day 6 of progesterone treatment, at which point responsiveness to 
oxytocin is highest, so receptor concentrations do not appear to be a limiting factor in the 
regulation of luteolysis by progesterone (Mann et al., 2001). 
Progesterone is necessary for synthesis of PGF2α, as it induces production of 
prostaglandin synthetase (cyclooxygenase) and phospholipase C regulatory enzymes 
(Raw et al., 1988; Raw et al., 1991; Salamonson et al., 1991).  It has also been 
determined that while estradiol 17β has no effect on endometrial epithelial prostaglandin 
synthase levels, progesterone stimulates its production (Salamonson et al., 1991).  This is 
an important observation, as prostaglandin synthase is the enzyme that converts 
arachidonic acid to the intermediary prostaglandins G and H, which are then converted to 
PGF2α and other prostaglandins (Salamonson et al., 1991).  Progesterone also appears to 
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regulate expression of the endometrial gene encoding cyclooxygenase, which is the rate-
limiting enzyme in the metabolism of arachidonic acid to PGF2α (Eggleston et al., 1990).  
These observations support the concept that progesterone is an adept regulator of the 
onset of uterine secretion of PGF2α in the luteolytic mechanism. 
Exogenously applied progesterone can alter the length of the cycle with the 
degree of its effect being dependent on the stage of the estrous cycle during which 
treatment is initiated (Woody et al., 1967a; Lewis et al., 1968; Ginther, 1969).  
Additionally, its effect seems to be dose-dependent to an extent; for example, a single 
large dose of progesterone given on the day of or one day following estrus reduced the 
length of the estrous cycle by 7-10 days (Thwaites et al., 1971; Dixon et al., 1973).  A 
number of other studies have found that exogenous treatment with progesterone 
shortened the length of the cycle when given early in the cycle regardless of the route of 
administration (Woody et al., 1967; Thwaites, 1971; Lewis et al., 1968; Dixon et al., 
1973; Ottobre et al., 1980). 
The degree to which progesterone shortens the cycle appears to depend upon the 
time that it is first administered.  It has been observed that progesterone’s effect on cycle 
length reduction diminished as progesterone treatment was delayed from around 
metestrus (day 0-3) to a few days later in the cycle (day 4-7) (Ginther et al., 1968; 
Ginther et al., 1969).  Additionally, treatment with progesterone later (days 12-15) tended 
to lengthen the estrous cycle, presumably through inhibition of ovulation and estrus 
(Ginther et al., 1969).  The length of the estrous cycle tended to be reduced in intact 
compared to hysterectomized progesterone-treated ewes (Woody et al., 1968).  This 
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suggests that progesterone-mediated luteolysis requires uterine components, which has 
been abundantly established to be through endometrial release of PGF2α. 
Other studies have supported the proposition that the luteolytic effect of 
exogenous progesterone given early in the estrous cycle is mediated by an increase either 
in the synthesis or secretion of prostaglandin F2α by the uterus between days 8-11 of the 
cycle (Lewis et al., 1977).  This has been supported by other work involving use of 
ovariectomized ewes with autotransplanted uteri, where treatment with progesterone for 7 
or 14 days increased the mean concentration of PGF2α (Scaramuzzi et al., 1977).  
Whereas progesterone by itself has been shown to increase production of PGF2α in 
ovariectomized ewes, application of exogenous estrogen has not produced the same effect 
(Caldwell et al., 1972).  However, when estrogen is administered following sufficient 
pretreatment with progesterone, maximal secretion of PGF2α occurs (Caldwell et al., 
1972; Louis et al., 1977; Scaramuzzi et al., 1977).  This is logical, as in the natural cycle 
estrogen would be secreted in increasing amounts during proestrus following priming by 
luteal progesterone and has experimentally been shown to produce a maximal luteolytic 
effect when combined with PGF2α above prostaglandin alone in hysterectomized ewes 
(Gengenbach et al., 1977). 
It had also been proposed that progesterone’s effect on inducing premature 
luteolysis could be due to suppression of luteotropins (Ottobre et al., 1980).  In immature, 
ovariectomized, and mature ewes, it was observed that treatment with progesterone 
decreased LH secretion so this could be a contributing factor to decreasing the lifespan of 
these corpora lutea (Karsch et al., 1977; Foster and Karsch, 1976; Ottobre et al., 1980).  
Supplementation with exogenous LH or HCG, which is LH-like, early in the cycle has 
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been shown to partially negate the early luteolysis-inducing effect of progesterone, but 
additional corpora lutea were often formed with addition of these hormones (Lewis et al., 
1968).  Around the time of ovulation, it has been shown to be unlikely that the cycle 
length is decreased as a result of reduced LH surges, because cycle length was not 
correlated with peak levels of LH in either progesterone-treated or control ewes (Ottobre 
et al., 1980).  This is supported by other work in which progesterone administered after 
the LH surge still shortened the length of the cycle (Dixon and Thwaites, 1973; Lewis et 
al., 1968; Thwaites, 1971).  Nonetheless, reduced LH concentrations could be a 
contributing factor by increasing the sensitivity of the corpus luteum to prostaglandin 
(Ottobre et al., 1980).  However, secretion of PGF2α appears to have a more potent effect 
on luteolysis than luteotropic factors (Woody et al., 1968; Ginther, 1968; Lewis et al., 
1977).  These results are supportive of the concept that the initial rise in PGF2α occurs in 
response to exogenous progesterone (or that secreted by the corpus luteum in the 
unaltered cycle). 
 Typically in short-term protocols a portion of ewes will not respond to treatment 
as a result of having corpora lutea that may not have adequate time to regress naturally 
during the short treatment period.  The progesterone pretreatment will prevent the 
formation of any new luteal tissue and ensure that any resulting corpora lutea are at least 
5 days old (if a 5 day progesterone pretreatment is used) so are therefore sensitive to 
PGF2α (Beck et al., 1993).  Exogenous PGF2α can be included at the beginning or end of 
the treatment period in order to regress any existing corpora lutea that may remain, and 
additionally prostaglandin has been demonstrated to be capable of inducing ovulation 
when used with progestagen treatment with its effect likely being exerted directly on the 
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ovary (Davies et al., 2006).  Therefore at cessation of treatment with progesterone, 
because all ewes should have no remaining corpora lutea, the inhibitory effect on the 
hypothalamus and anterior pituitary gland should be removed and ewes should enter the 
follicular phase in a controlled manner. 
In conclusion, progesterone treatments can also contribute to synchronizing estrus 
by inducing an early onset of luteolysis when given early in the cycle.  The maintainance 
of a high concentration of progesterone later in the cycle would block estrus and 
ovulation until cessation of progestational treatment.  This occurs due to the inhibitory 
characteristic of progesterone on reducing the frequency of GnRH pulses, thereby 
preventing the LH surge required for ovulation (Inskeep, 2005).  At progesterone 
removal, ovulation can ensue in ewes that were in the follicular phase at device insertion, 
and corpora lutea will have been regressed in most ewes that were in the luteal phase at 
CIDR insertion. 
V. Effects of Application of Synthetic PGF2α on Components of the Estrous Cycle 
Single injection regimens can produce poor synchrony due to the fact that the day 
of the cycle in which PGF2α is administered influences the interval to the onset of estrus.  
The duration to the onset of estrus has been found to be positively correlated with the 
stage of the estrous cycle, with ewes treated earlier showing an earlier onset and those 
later showing a delayed onset (Acritopoulou and Haresign, 1980; Deaver et al., 1986; 
Houghton et al., 1995).  This is based on the variation in time necessary to reduce the 
elevated progesterone to its basal level, as corpora lutea gain their maximal endocrine 
functionality later in the luteal phase (Deaver et al., 1986; Houghton et al., 1995).  These 
disparities in the interval to the onset of estrus could also conceivably be attributed to the 
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size of follicles present at luteolysis as there is a greater mixture of growing, static, and 
atretic follicles in the mid- to late-luteal phase (Houghton et al., 1995). 
The day of cycle at which prostaglandin is administered throughout the luteal 
phase is also known to influence other components of the estrous cycle, including 
follicular function, growth, and maturation as well as the origin of the preovulatory 
follicle (POF) (Abecia et al., 2011; Vinoles and Rubianes, 1998).  Ewes injected with 
PGF2α that are in the mid-luteal phase have been observed to typically have their POF 
originating from the second wave (Vinoles and Rubianes, 1998).  However, ewes in the 
early luteal phase can have their POF derived from either the first or second wave, 
depending on the status of the dominant follicle (growing, static, or regressing) (Vinoles 
and Rubianes, 1998).  PGF2α administration during the mid-luteal phase could result in 
compromised follicular function from the induction of lower levels of LH as a result of a 
higher progesterone concentration (Deaver et al., 1986; Campbell et al., 1995; Gonzalez-
Bulnes et al., 2004).  Additionally, injection during the endogenous FSH peak during the 
mid-luteal phase has been observed to result in disruption of the endogenous FSH 
secretion pattern and was associated with untimely follicular rupture and luteal 
inadequacy (Liu et al., 2006). 
Induction of luteolysis during the early luteal phase has also been associated with 
a higher sustained concentration of plasma FSH, whereas treatment at later stages was 
followed by a significant decrease (Deaver et al., 1986).  The possibility of compromised 
follicular function would be a conceivable outcome, as gonadotropins are imperative for 
maintaining the steroidogenic capacity of preovulatory follicles.  With LH being 
necessary for final follicular growth and maturation, follicular functionality could 
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therefore be impaired (Deaver et al., 1986; Campbell et al., 1995).  Therefore, these 
observations suggest that the early or late luteal phase would be a more ideal endocrine 
setting for induction of luteolysis. 
Despite the varying endocrinological setting among different stages of the luteal 
phase, no differences have been observed between ovulation rate or duration of estrus 
based on stage of the estrous cycle with PGF2α treatment (Deaver et al., 1986; Houghton 
et al., 1995; Barrett et al., 2002).  However, greater follicular recruitment has been 
observed early and late in the estrous cycle, during which time progesterone is low 
(Brand and de Jong, 1973; Schrick et al., 1993).  Additionally, ewes with low expected 
circulating progesterone have been observed to have an increased ovulation rate, as found 
in a study where ewes’ endogenous progesterone was removed (through induced 
luteolysis) and was replaced with lower circulating concentrations with intravaginal 
inserts (Devonish et al., 2009).  Breed differences have also been found, with more 
prolific Finnsheep having a lower luteal progesterone concentration and a higher 
ovulation rate and less prolific Western white-faced ewes having a higher progesterone 
concentration and lower ovulation rate (Bartlewski et al., 1999).  However, this would 
suggest the potential for an observable improvement in lambing outcomes from induced 
luteolysis in ewes at the early versus mid- to late-luteal phase. 
One study has investigated lambing outcomes in ewes separated into individual 
groups undergoing induced luteolysis between days 5-11 after ovulation and, converse to 
other studies, found no difference between group means for duration of time from 
treatment to onset of estrus (Schoombee, 1996).  Additionally, similarly low conception 
rates were observed among all groups and no differences were detected among lambing 
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outcomes (Schoombee, 1996).  However, the suboptimal dose of 10 mg of PGF2α used in 
the experiment in combination with artificial insemination and exceedingly small samples 
sizes (4-14 ewes per group) allow for ample improvement in further studies to more 
accurately detect potential differences in lambing outcomes between treatment groups. 
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STATEMENT OF THE PROBLEM 
 
 Estrous synchronization is an important component of reproductive management 
of farm animal species.  An important objective of efficient estrous synchronization in 
sheep operations is to provide a cost-effective mode of synchronizing parturitions in 
order to produce offspring at a desired timepoint, facilitate better assignment of labor, 
reduce neonatal mortality, and improve strategic marketing of lambs in order to increase 
farm production and profitability.  Over the past 70 years, a number of methods have 
been developed which have primarily been founded upon either progestogen or 
prostaglandin-based treatments.  Traditional progestogen-based approaches have often 
resulted in decreased fertility and have required a long treatment period but have 
typically resulted in greater estrus synchronization rates than prostaglandin-based 
approaches. 
Short-term progestogen treatments in combination with PGF2α have been 
demonstrated to be an effective method for synchronizing estrus, but present a 30% 
increase in treatment cost over progestogen treatment alone, and combining progesterone 
with PGF2α resulted in a negative effect on ewe fertility (D’Souza et al., 2011).  Results 
from recent studies indicate that PGF2α inclusion may not be necessary with short-term 
progestogen to induce a synchronized estrus (D’Souza et al., 2011).  Therefore, it is 
necessary to further evaluate the effect of PGF2α on ewe fertility and to determine if the 
time of PGF2α injection relative to application of progesterone significantly impacts ewe 
fertility in order to justify its inclusion in short-term progestogen-based protocols. 
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Review of existing literature provided evidence that at different stages of the 
estrous cycle, follicular development deviates in association with varying concentrations 
of circulating progesterone.  Research performed on the effect of PGF2α injected at 
different stages of the estrous cycle has shown variations in follicular development and 
origin of the preovulatory follicle; time of ovulation; estrus response, duration to onset of 
estrus; and concentrations of ovarian and pituitary hormones.  Therefore, overall 
reproductive outcomes following use of PGF2α in estrous synchronization protocols 
might be dependent on the day of the estrous cycle on which luteolysis is induced.  
However, few studies have evaluated the potential effect of PGF2α injection at different 
stages of the luteal phase on final reproductive outcomes, and those that have were 
conducted with a number of suboptimal experimental conditions, including small sample 
sizes, use of a substandard dose of PGF2α, and use of artificial insemination rather than 
natural service.  Therefore, the objective of the second study was to evaluate if day of the 
cycle on which PGF2α is administered affects ewe fertility. 
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INTRODUCTION 
 
 Efficient methods of estrous synchronization are essential for optimizing the 
productivity and profitability of breeding operations by reducing the time and cost 
associated with lambing and producing a more uniform lamb crop that can be 
strategically targeted to specific markets.  Over the past few decades, the sheep industry 
has been in a state of continuous decline, and increased reproductive efficiency could 
help revive the state of the industry (Knights et al., 2003).  Estrus synchronization 
approaches have been based primarily upon their effect on manipulating the natural ovine 
luteal phase, which can be defined as the length of time during which one or more 
corpora lutea are present on the ovary (Senger, 2012).  Most approaches used to 
synchronize estrus are based on either shortening the luteal phase through treatment with 
a luteolytic dose of prostaglandin F2α (PGF2α) or by using progestogens to provide an 
artificial luteal phase for 12-14 days, during which existing corpora lutea would have 
sufficient time to regress through endogenously produced PGF2α (Dutt and Casida, 1948; 
Robinson, 1964; Allison and Kelly, 1978).  However, regimens using a single injection of 
PGF2α are only effective in synchronizing estrus in the approximately 66% of ewes in a 
flock that are between days 4-14 of the estrous cycle and have corpora lutea that are 
responsive to PGF2α (Acritopoulou and Haresign, 1980).  Other prostaglandin-based 
regimens have been developed that use multiple injections and have had variable success 
(Boland et al., 1978; Allison et al., 1978). 
 Typical estrous synchronization rates associated with prostaglandin-based and 
progestogen-based protocols are approximately 70% and 80% respectively (Gonzalez-
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Bulnes et al., 2002; Simonetti et al., 2000).  Because the fertility obtained from a 
particular estrous synchronization method typically determines its feasibility, long term 
progestogen-based synchronization approaches have generally been preferred over 
PGF2α-based methods.  Based on the assumption that progestogen treatment must span 
the length of the natural ovine luteal phase in order to ensure the absence of luteal tissue 
at treatment cessation, traditional progestogen-based protocols were utilized for 12-14 
days or longer (Dutt and Casida, 1948).  Long-term treatments have also been implicated 
in a reduction in the total number of follicles present as well as an impairment in the 
viability of resulting embryos (Gonzalez-Bulnes et al., 2005).  Long-term treatments 
could be associated with subluteal concentrations of progesterone.  Studies using 
progesterone containing delivery devices have demonstrated that after 72 hours 
circulating progesterone levels continually decrease (Wheaton, 1993).  Subluteal 
concentrations of progesterone have been implicated with development of large (Dutt and 
Casida, 1948) or persistent follicles (Johnson et al., 1996).  Ewes exposed to a subluteal 
concentration of progesterone during estrous synchronization treatment have also been 
observed to have decreased fertility compared to control ewes in some studies (Johnson 
et al., 1998; Robinson et al., 1970), whereas in other studies (Evans et al., 2001) no 
difference has been observed. 
 Short-term progestogen treatments provide a higher mean circulating 
concentration of progesterone over the shorter duration of treatment and recent studies 
have provided evidence that short-term treatments can result in higher pregnancy rates 
than long-term treatments (87 vs. 63%; Vinoles et al., 2001).  The higher pregnancy rate 
obtained in ewes receiving the short-term progestogen treatment was also related to a 
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more rapid follicular turnover and the ovulation of more newly recruited follicles in 
comparison with ewes receiving a longer period of progestogen treatment (Vinoles et al., 
2001). 
Due to the fact that it was universally believed that it was necessary for the 
duration of progestogen treatment to span the entirety of the natural luteal phase, most 
studies utilizing short-term progestogen treatments have used them in combination with 
PGF2α at progestogen withdrawal (Loubser and Van Niekerk, 1981; Fitzgerald et al., 
1985; Beck et al., 1993; Dixon et al., 2006).  These treatments have been effective, as the 
progestogen pretreatment prevents formation of corpora lutea for the duration of 
treatment, which ensures that any existing corpora lutea at the end of pretreatment are 
sensitive to an applied luteolytic dose of PGF2α (Acritopoulou et al., 1980; Beck et al., 
1993).  For example, prior studies have shown an enhanced estrus response (84 vs. 62%) 
and first service pregnancy rates (64 vs. 44%) with combination treatments over PGF2α 
alone (Dixon et al., 2006).  However, despite the high degree of synchrony produced by 
short-term combination treatments, the inclusion of PGF2α costs approximately 30% 
more, which limits the adoption of the hormonal combination for synchronization of 
estrus in commercial flocks. 
The potential use of short-term progestogen-based treatments was first suggested 
in 1967 through a study where it was observed that administration of progesterone early 
in the estrous cycle would shorten the cycle through premature luteal regression (Woody 
et al., 1967).  Several studies thereafter validated the original observation and 
demonstrated that progesterone plays a major role in establishing the timing of PGF2α   
release (Thwaites, 1971; Lewis et al., 1968; Dixon et al., 1973, Ottobre et al., 1980).  
	   	   	   31	  
However, few studies on estrous synchronization in sheep have been conducted using a 
short-term progestogen treatment without concomitant application of PGF2α.  More 
recently, treatment with progesterone for 5 days alone resulted in higher conception rates 
(67 vs 53%) and first service pregnancy rates (58 vs. 44%) with no difference in estrous 
response (82%) compared to using short-term progesterone treatment with inclusion of 
PGF2α (D’Souza et al., 2011). 
 It is also known that day of cycle on which PGF2α is administered influences a 
number of variables, including the interval to the onset of estrus (Acritopoulou and 
Haresign, 1980; Deaver et al., 1986).  Ewes injected with PGF2α earlier in the estrous 
cycle have a more rapid onset to estrus (day 5, 36 hours; day 8, 41 hours; day 11, 48 
hours) (Houghton et al., 1995).  This is based on the variation in time necessary to reduce 
the elevated progesterone to its basal level, as corpora lutea gain maximal endocrine 
functionality as they mature (Deaver et al., 1986; Houghton et al., 1995).  It has also been 
shown follicular dynamics vary with the day of the estrous cycle, as ewes in the mid- to 
late-luteal phase have a greater mixture of growing, static, and atretic follicles than those 
in the early luteal phase (Houghton et al., 1995).  Ewes treated during the early luteal 
phase have a higher sustained concentration of FSH and higher concentrations of LH 
(Deaver et al., 1986).  It has been suggested that treatments with PGF2α later in the cycle 
could result in compromised follicular function as a result from greater inhibition of LH 
release by the higher circulating concentration of progesterone (Deaver et al., 1986; 
Campbell et al., 1995; Gonzalez-Bulnes et al., 2004).  Therefore, the objectives of this 
study were 1) to evaluate the necessity and potential effect of time of application of 
exogenous PGF2α relative to progesterone treatment as part of a short-term progesterone-
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based estrous synchronization protocol and 2) to determine if the day of cycle at which 
luteolysis is induced influences reproductive outcomes. 
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MATERIALS AND METHODS 
 
General 
  Mature, non-lactating ewes of mixed breeding were managed on mixed grass 
legume pastures, and were supplemented with hay as needed and provided with water ad 
libitum.  Ewes were brought into holding pens for treatment and pregnancy diagnoses.  
Ewes were studied during the fall breeding season in August 2013 and August 2014.  All 
ewes were separated from rams for a minimum of 30 days prior to the beginning of each 
experiment.  All rams were sexually mature and of proven fertility, and were used at a 
ram:ewe ratio no greater than 1:20. 
 
Treatments 
All experimental procedures were approved by the West Virginia University Animal 
Care and Use Committee (protocol #10-1102). 
 
Experiment 1 
In order to evaluate the effect of time of application of PGF2α relative to treatment 
with progesterone on fertility, ewes  (N=442) from 4 farms located in WV and PA were 
randomly assigned to receive progesterone using a controlled internal drug-releasing 
device (CIDR-g, 0.3 g progesterone; Zoetis, Florham Park, NJ) for 5 days alone (n=123; 
treatment 1), in combination with 25 mg PGF2α (5 mL Lutalyse; Dinoprost 
Tromethamine; Zoetis, Florham Park, NJ) via intramuscular injection at CIDR insertion 
(n=103; treatment 2) or removal (n=100; treatment 3), or 25 mg PGF2α alone (n=116; 
treatment 4) prior to being joined with sexually mature rams. 
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Experiment 2 
This study was designed to compare reproductive performance in ewes treated 
with PGF2α at different stages of the estrous cycle.  The estrous cycle of ewes (N=148) 
from 1 farm located in southwestern Pennsylvania were pre-synchronized using treatment 
with a CIDR device for 7 days.  This treatment was shown to be effective in 
synchronizing estrus in approximately 82% of ewes within 2-3 days after removal (day 0; 
D’Souza et al., 2011).  Ewes were randomly assigned to receive a 25 mg intramuscular 
injection of PGF2α 7 (n=48), 10 (n=50), or 13 (n=50) days following CIDR removal 
which was projected to be equivalent to day 5, 8, and 11 of the estrous cycle, and 
sexually mature rams were introduced to all ewes at PGF2α injection (figure 1). 
Blood was collected via jugular venipuncture into heparinized tubes (EDTA; 
Monoject, 15% EDTA K3 liquid, Tyco Healthcare Group, Mansfield, Massachusetts, 
USA) two days post-CIDR removal, the day of PGF2α injection, and the day following 
PGF2α injection to determine progesterone concentration for comparison across groups as 
well as to verify treatment effect.  Thirty-three ewes (n=11 per treatment) that expressed 
estrus after PGF2α injection were chosen for analysis of plasma progesterone 
concentration.  Plasma was separated via centrifugation for 15 minutes at 3500 rotations 
per minute and pipetting and stored at -20̊ C until assayed for progesterone (PROG-RIA-
CT; DIAsource ImmunoAssays, Louvain-La-Neuve Belgium).	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Figure 1.  Logistical timeline of Experiment 2 methodology  
 
 
Estrous Detection 
 
Rams were raddled with paint crayons in harnesses on their briskets and estrus 
response was evaluated in both experiments through visual inspection for rump marks on 
ewes three days following ram introduction at all farms. 
 
Pregnancy Diagnosis and Lambing Data 
 
Ultrasonographic observations for pregnancy diagnoses in experiments 1 and 2 
(Schrick and Inskeep, 1993), were made at 30-35 days after ram introduction to 
determine pregnancy to the first service and again 50-55 days post-ram introduction to 
determine pregnancy to the second service at all farms.  Ewes were scanned via 
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transrectal ultrasonography using an Aloka 500 console equipped with a 7.5 mHz linear 
array transducer (Corometrics Medical Systems, Wallingford, CT).  Lambing records, 
including dates and numbers of lambs born per ewe, were recorded in both experiments. 
 
Statistical Analyses 
 
Data were analyzed in both experiments through analysis of variance using the 
GLM procedure of SAS (SAS Inst. Inc., Cary, NC) with the model consisting of the main 
effects of treatments, farms (experiment 1) and their interactions (experiment 1) and 
additionally, least square means for treatment effects were determined.  Response 
variables included overall prolificacy (number of lambs born per ewe lambing), first 
service prolificacy, the interval from ram introduction to lambing, the mean lambing day 
(the day that a ewe lambed during the lambing period) and lambing rates (the number of 
lambs born per ewe treated).  Other response variables evaluated were estrous response, 
conception rate, pregnancy rate to first and second services, and proportion of ewes 
lambing to the first service period. 
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RESULTS 
 
Experiment 1 
 The mean response variables for ewes treated with PGF2α at different timepoints 
in relation to short-term CIDR use are summarized in table 1.  Estrous response did not 
differ among ewes receiving progesterone-based treatments but was significantly lower in 
ewes receiving PGF2α only (p=0.005; table 1).  Conception rates tended to be higher in 
CIDR only than ewes receiving CIDR and PGF2α at device insertion (p=0.07).  Pregnancy 
rate to first service was higher in ewes receiving CIDR devices only (p=0.03) than ewes 
receiving PGF2α alone and at device removal (figure 2).  Mean second service pregnancy 
rates were 82.4% and did not differ between groups (figure 2). 
 
Overall prolificacy did not differ with treatment, but prolificacy to first service 
was significantly higher (p=0.05) in ewes receiving PGF2α only compared to ewes 
receiving PGF2α at device removal.  The percent of ewes lambing to first service was 
greater in ewes treated with CIDR only than in both ewes treated with PGF2α only 
(p=0.05) and in ewes treated with PGF2α at CIDR removal.  Ewes lambing to first service 
was also higher in ewes treated with PGF2α at CIDR insertion than in ewes treated with 
PGF2α only (p=0.02) and tended to be higher than ewes treated with PGF2α at CIDR 
removal than ewes treated with PGF2α only (p=0.10).  There were no effects of treatments 
on mean interval from ram introduction to lambing (159 ± 3.2 days), lambing day (15.2 ± 
3.2 days), and percent lambed (89.9 ± 5.5%). 
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Table 1.  Reproductive performance of ewes in response to a 5 day progesterone treatment alone 
or in combination with PGF2α at insert removal or insertion or PGF2α alone (experiment 1). 
 
Variable 
Treatment 
CIDR only CIDR + 
PGF at 
Insertion 
CIDR + 
PGF at 
Removal 
PGF only 
Estrous response (%) 85.6 ± 3.7b 84.1 ± 4.2b 83.0 ± 4.2b 66.5 ± 4.0a 
Conception Rate (%) 73.3 ± 4.6a 65.0 ± 5.3b 60.7 ± 5.4ab 74.5 ± 9.5ab 
1st Service Pregnancy Rate (%) 67.7 ± 4.4a 58.3 ± 4.9ab 53.8 ± 4.9b 48.7 ± 4.7b 
2nd Service Pregnancy Rate (%) 83.4 ± 3.9 85.2 ± 4.3 80.4 ± 4.3 81.7 ± 4.2 
1st Service Prolificacy 1.45 ± .10ab 1.64 ± .12ab 1.30 ± .17b 1.75 ± .15a 
Overall Prolificacy 1.56 ± .07 1.59 ± .08 1.51 ± .08 1.64 ± .08 
Lambing to 1st Service 54.0 ± 4.6a 52.3 ± 5.2ab 40.3 ± 5.3bc 35.2 ± 5.0c 
Ram Introduction to Lambing (d) 158.4 ± 1.2 157.4 ± 1.4 160.6 ± 1.4 160.2 ± 1.3 
Lambing day (d) 14.4 ± 1.2 13.4 ± 1.4 16.5 ± 1.4 16.2 ± 1.3 
Lambed (%) 89.1 ± 4.0 90.4 ± 4.0 92.8 ± 4.3 86.2 ± 3.5 
Values with differing superscripts across a row are significantly different (p≤.05) or have a 
tendency to differ (p≤.10). 
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Figure 2.  Pregnancy rate, determined as the percent of ewes diagnosed as pregnant of ewes exposed via 
transrectal ultrasonography 30 days (1st service period) or 50 days (both service periods) following ram 
introduction.  Values with differing letters represent significant differences (p<0.05). 
 
 
Figure 3.  Lambing percent to the first service period was calculated as the number of lambs born within 
the first 15 days of the lambing period per ewe exposed.  Values with differing letters represent significant 
differences (p≤0.05). 
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Experiment 2:  Reproductive Variables and Hormonal Analysis 
 
The mean progesterone concentration measured at predicted day 0 was 3.06 ng/ml 
and did not differ by treatment.  Ewes predicted to be on day 5 of the estrous cycle had a 
significantly lower mean progesterone concentration compared to ewes predicted to be on 
day 8 and 11 (p<0.001; 2.93 ± .34 vs. 4.62 ± .34, 5.16 ± .34 ng/ml, table 2).  At 24 hours 
following induction of luteolysis, the mean progesterone concentration decreased to 2.2 
ng/ml and did not differ by treatment (Table 2; figure 8). 
 
Table 2.  Mean progesterone concentrations measured at predicted day of cycle (5, 8, and 11) at 
different experimental timepoints 
 
Timepoint of Measurement 
Mean Progesterone Concentration 
(ng/ml) 
 
P-value 
Day 5 Day 8 Day 11 
Predicted Day 0 3.07 ± .34 2.96 ± .37 3.15 ± .34 NS 
Predicted Group Day 2.93 ± .34a 4.62 ± .34b 5.16 ± .34b <.001 
24 Hours after PGF2α Injection 1.99 ± .34 2.26 ± .35 2.35 ± .34 NS 
Values with differing superscripts across a row are significantly different (p≤0.05).  NS=not 
significantly different. 
 
 The mean values of reproductive variables for ewes treated with 25 mg PGF2α at 
projected day 5, 8, and 11 of the estrous cycle are summarized in table 3.  Mean estrous 
response was 85.1% and did not differ with treatment.  Conception rate was higher in 
ewes injected with PGF2α at predicted day 5 than those injected at day 11 (p<0.05; table 
3; figure 4) and tended to be higher than ewes injected on day 8 (p<0.1). 
Pregnancy rate to first service tended to be higher in ewes injected on day 5 than 
those injected on day 11 (p=0.07; table 3).  The mean pregnancy rate to both service 
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periods did not differ (93.9 ± 4.9%; figure 5).  Overall prolificacy was 1.54 and did not 
differ with treatment. 
Prolificacy of ewes lambing to the first service period was greater in ewes 
injected on day 5 than those injected on day 11 (p=0.05; figure 6) and was intermediate in 
ewes injected with PGF2α at predicted day 8 (p=0.1).  More ewes lambed to first service 
when injected with PGF2α at day 5 than those injected at either day 8 or 11 (p=0.05; 
figure 7), but the overall mean lambing percent was not affected by treatments.  The 
mean interval from ram introduction to lambing and the lambing day were shorter in 
ewes injected with PGF2α on day 5 than ewes in other treatment groups (p=0.002). 
 
Table 3.  Reproductive performance of ewes in response to PGF2α treatment on predicted days 5, 
8, and 11 of the estrous cycle (experiment 2). 
 
Variable 
Stage of Estrous Cycle 
Day 5 (n=48) Day 8 
(n=50) 
Day 11 
(n=50) 
Estrous response (%) 85.4 ± 5.2 84.0 ± 5.1 86.0 ± 5.1 
Conception Rate (%) 70.7 ± 7.7a 52.3 ± 7.6ab 48.8 ± 7.5b 
1st Service Pregnancy Rate (%) 62.5 ± 7.2a 48.0 ± 7.1ab 44.0 ± 7.1b 
2nd Service Pregnancy Rate (%) 89.6 ± 3.5 96.0 ± 3.4 96.0 ± 3.4 
1st Service Prolificacy 1.67 ± .11a 1.40 ± .14ab 1.33 ± .13b 
Overall Prolificacy 1.56 ± .09 1.56 ± .09 1.51 ± .09 
Lambing to 1st Service 57.4 ± 7.0a 30.0 ± 6.8b 36.0 ± 6.8b 
Ram Introduction to Lambing (d) 153.7 ± 1.4a 160.9 ± 1.3b 159.7 ± 1.4b 
Lambing day (d) 10.7 ± 1.4a 17.9 ± 1.3b 16.7 ± 1.4b 
Lambed (%) 85.4 ± 5.1 90.0 ± 5.0 82.0 ± 5.0 
Values with differing superscripts across a row are significantly different (p≤0.05) or have a 
tendency to differ (p≤0.10).  
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Figure 4.  Conception rate was calculated as the number of ewes diagnosed as pregnant at 30 days (1st 
service) of the ewes that were observed to be in estrus by 72 hours following ram introduction.  Values 
with differing letters represent significant differences (p<0.05). 
 
Figure 5.  Pregnancy rate, determined as the percent of ewes diagnosed as pregnant of ewes exposed via 
transrectal ultrasonography 30 days (1st service period) or 50 days (2nd service period) following ram 
introduction.  Values with differing letters represent a tendency to differ between treatment groups 
(p=0.07). 
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Figure 6.  Prolificacy: the number of lambs born per ewe lambing to the first service period (first 15 days of 
the lambing period).  Values with differing letters represent significant differences (p=0.05). 
 
 
 
Figure 7.  Lambing percent to the first service period was calculated as the number of lambs born within 
the first 15 days of the lambing period per ewe exposed.  Values with differing letters represent significant 
differences (p<0.05). 
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Figure 8.  Mean progesterone concentration measured across groups at different predicted days of cycle at 
which luteolysis was induced with PGF2α, being day 5 (blue), day 8 (yellow), and day 11 (orange).  Mean 
concentrations were obtained from plasma collected at the predicted day 0 (48 hours after CIDR removal), 
at PGF2α injection, and 24 hours following application of PGF2α. 
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DISCUSSION 
 
The mean estrous response of ewes treated with progesterone both alone as well 
as in combination with PGF2α was approximately 84%.  D’Souza et al. (2011) observed 
no difference between ewes receiving progesterone treatment alone versus those 
additionally receiving PGF2α (82%), which is in direct agreement with outcomes of this 
experiment.  Additionally, estrus rates of 89% (Fitzgerald et al., 1985), 84% (Dixon et al., 
2006), 93% (Ozturkler et al., 2003), and 100% (Beck et al., 1993; Greyling et al., 1979) 
have been previously observed with the use of combination treatments.  The response 
obtained from the current study did not differ significantly among ewes receiving 
progesterone pretreatment (84%), but was lower in ewes treated only with PGF2α.  This is 
consistent with the findings of Acritopoulou and Haresign (1980), who estimated that a 
single injection of PGF2α to a flock of randomly cycling ewes would synchronize 66% of 
treated ewes, as that would be the approximate proportion of ewes in the luteal phase 
with a CL sensitive to luteolysins (day 4-14) at any given time.  Other studies using 
PGF2α only regimens have produced similar estrus responses of 62.5% (Dixon et al., 
2006) and 52.9% (Beck et al., 1993). 
Few other studies have been conducted using short-term progesterone treatment 
alone in an attempt to synchronize estrus in ewes.  Vinoles et al. (2001) obtained an 
estrus percentage of 95%, albeit estrus was measured at 144 hours following device 
removal.  While the CIDR only group in this experiment had the highest first service 
pregnancy rate of treatment groups (67.7 ± 4.4%), the first service pregnancy response 
obtained by Vinoles et al. with short-term progestogen use was exceptionally high (87%).  
	   	   	   46	  
In that study, ewes receiving short-term progestogen treatment were observed to have a 
more rapid follicular turnover as well as ovulation of a more newly recruited follicle 
(Vinoles et al., 2001).  This was thought to be associated with higher progestagen levels 
supplied by the shorter duration of treatment (in comparison with ewes receiving 
progestogen for 12 days).  It has also been suggested that short-term treatments providing 
a shorter period of exposure to progestogens could be less disruptive to ovarian function 
(Fitzgerald et al., 1985).  These could help explain the increased pregnancy rate obtained 
with short-term progestogen use. 
Other studies have evaluated combination of progestogen treatment with that of 
prostaglandin the day before (Dixon et al., 2006; Fitzgerald et al., 1985) or the day of 
(Ozturkler et al., 2003; Dixon et al., 2006; D’Souza et al., 2011; Loubser and Van 
Niekerk, 1981; Greyling et al., 1979; Beck et al., 1993) device removal.  These studies 
did not seek to determine whether the timing of PGF2α administration had an effect on 
resulting fertility, but compared the combination treatments with those of PGF2α or 
progestogen alone.  Results from the current study did not detect a general improvement 
in reproductive outcomes at either timepoint of PGF2α injection with short-term 
progesterone use in comparison with progesterone treatment alone. 
The conception rate resulting from progesterone treatment alone tended to be 
higher than ewes receiving progesterone and PGF2α at device insertion, and has provided 
a value similar to that found in a similar study using 5-7 day progesterone treatment 
without inclusion of PGF2α (D’Souza et al., 2011).  Conception rates from other studies 
using combination treatments have been 77% (Dixon et al., 2006), 53% (D’Souza et al., 
2011), 86% (Beck et al., 1993), and 89% (Fitzgerald et al., 1985).  Ewes receiving PGF2α 
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only have been previously observed to have similar conception rates to that observed in 
the present study (74.5 ± 9.5%) of 72.0% (Dixon et al., 2006), while others have found 
lower rates of 44.3% (Beck et al., 1993). 
In this study, progesterone-treated ewes had a higher lambing percent to first 
service (54%) compared with ewes treated with PGF2α only (35%).  This effectively 
shifted the lambing pattern to be more concentrated earlier in the season in ewes treated 
with progesterone than those receiving PGF2α only (table 1).  This is similar to previous 
data (45.8%) of ewes receiving only short-term progesterone treatment (D’Souza et al., 
2011) and those receiving both progesterone and PGF2α (56%; Dixon et al., 2006). 
Pretreatment of ewes with only progesterone for 5 days was sufficient to induce 
fertile estrus in a high proportion of ewes, which confirms earlier results from similar 
studies (D’Souza et al., 2011).  Additionally, progestagen treatment combined with 
PGF2α generally improved reproductive outcomes in comparison with PGF2α treatment 
alone, an observation which is in agreement with prior experimental results (Dixon et al., 
2006).  From a practical perspective these results are of benefit to sheep reproduction 
enterprises, as a 5 day progesterone pretreatment provides no reduction in fertility in 
comparison with short-term combination methods while maintaining the reduction in 
time required for synchronization.  Additionally, facilitation of its use is less laborious 
and provides a 30% reduction in cost over traditional short-term approaches. 
Treatment of ewes earlier in the luteal phase (day 5) confirmed our hypothesis 
and generally agreed with expectations from a review of the literature.  The time points of 
day 5, 8, and 11 were chosen as representative values of the early, mid-, and late luteal 
phase and have been used in similar studies (Deaver et al., 1986; Houghton et al., 1995).  
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Also, it has been shown that the ovine corpus luteum becomes sensitive to induction of 
luteolysis with exogenous PGF2α 3.5-4.0 days into the estrous cycle, with higher doses of 
PGF2α producing a greater response (Pope and Cardenas, 2004; Hackett and Robertson, 
1980).  Although prior studies utilized vasectomized rams in order to detect estrus to 
determine the day of estrous cycle in ewes, this was not logistically feasible in this study.  
Therefore, based on the average duration of time from removal of exogenous 
progesterone to the onset of estrus being 31.2 (Greyling and Brink, 1987) to 48 hours 
(Fitzgerald  et al., 1985) in ewes studied, groups were pre-treated with progesterone in 
order to synchronize estrus so that luteolysis could be induced using a luteolytic dose of 
PGF2α on predicted days 5, 8, or 11 of the estrous cycle. 
It has been established that the day of cycle at which luteolysis is induced 
influences the interval to the onset of estrus, with ewes treated earlier in the cycle having 
a shorter onset than ewes treated later in the cycle (Acritopoulou and Haresign, 1980; 
Deaver et al., 1986; Houghton et al., 1995).  This is dependent on the amount of time 
required for the concentration of progesterone to return to its basal level, and therefore is 
the longest when progesterone concentrations are highest later in the luteal phase 
(Houghton et al., 1995).  While estrus in this study was measured at a single time point 
72 hours following PGF2α injection and ram introduction, the expected trend was 
observed in both the ram introduction to lambing interval as well as in lambing day. 
The difference in the interval from induced luteolysis to estrus has been attributed 
to differences in the capability of large follicles to ovulate (Houghton et al., 1995).  Also, 
ewes with a lower circulating concentration of progesterone (day 5) have been shown to 
exhibit an earlier onset to estrus (Acritopoulou and Haresign, 1980; Deaver et al., 1986).  
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Therefore, they could be mated earlier and lamb earlier in the lambing period than ewes 
with a higher concentration of progesterone at luteolysis.  In the present experiment, the 
lambing day was significantly earlier in ewes treated on day 5 in comparison with other 
groups by approximately 7 and 6 days, respectively.  Additionally, in ewes treated earlier 
in the cycle, the ram to lamb interval was significantly shorter than that observed in day 8 
and day 11. The shorter duration from ram interval to lambing and earlier lambing day 
are consistent with the higher pregnancy and conception rates obtained with treatment 
with PGF2α earlier in the estrous cycle. 
Progesterone has been shown to be a potent inhibitor of GnRH and LH secretion, 
and lower concentrations of progesterone appear to be stimulatory to follicular growth 
(Karsch et al., 1977; McLeod et al., 1984; Johnson et al., 1996).  As progesterone is 
secreted maximally toward the end of the luteal phase, the reduction in fertility of ewes 
injected later in the cycle could be explained by poor final maturation of preovulatory 
follicles as a result of reduced LH secretion (Barrett et al., 2002).  Also, ewes undergoing 
induced luteolysis early in the luteal phase are exposed to a higher sustained 
concentration of FSH in comparison with ewes treated later in the cycle (Deaver et al., 
1986).  Gonadotropins are necessary for maintaining steroidogenic capacity, so it is 
conceivable that differences in conception rate and prolificacy at the first service period 
could be attributed to a degree of impaired follicular functionality in ewes induced at 
days 8 and 11 of the estrous cycle. 
Although ovulation rate was not measured in this study, a significantly greater 
prolificacy was obtained in ewes injected with PGF2α on day 5 than day 11 of their 
estrous cycles.  No differences in ovulation rate have been detected in previous studies 
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based on the day of cycle (Houghton et al., Deaver et al., 1986; Barrett et al., 2002) or 
peripheral progesterone concentration (Johnson et al., 1996), and only one study has 
measured lambing outcomes across treatment groups (Schoombee, 1996).  In that study 
(Schoombee, 1996), no difference was found between group means for conception rate 
(56.5%) or lambing outcomes, although group sizes were exceedingly small (4-14 
ewes/group) so it is likely that differences could not be detected from the limited sample 
sizes. 
Variations in follicular dynamics have been observed between the predicted 
stages of the estrous cycle used in this study.  For example, the ovulatory response of the 
largest follicles was found to be greatest in day 5 ewes (69%), least on day 8 (39%), and 
medial on day 11 (51%; Houghton et al., 1995).  Ovulatory response is related to size, 
location on the ovary, presence or absence of luteal tissue on the ovary, and the relative 
age of the follicle at luteolysis (Houghton et al., 1995).  Ewes in the mid-to late luteal 
phase have a greater combination of growing, static, and atretic follicles than ewes early 
in the luteal phase (Houghton et al., 1995).  Therefore, it would be logical that ewes 
undergoing induced luteolysis later in the estrous cycle will ovulate a smaller proportion 
of large follicles and will ovulate follicles less likely of establishing pregnancy. 
Ovulation rate is the primary determinant of litter size, but other factors are 
involved.  Because no differences have been detected in previous studies in ovulation rate 
among ewes treated with PGF2α during different stages of the estrous cycle, it is likely 
that litter size was influenced by a difference in embryonic mortality. Progesterone 
concentration was higher in ewes predicted to be at day 8 and 11 of the estrous cycle at 
induced luteolysis.  It has been well established that progesterone inhibits release of 
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gonadotropins, which are required for the final stages of follicular development and 
maturation.  It is conceivable that follicles induced to undergo luteolysis from periods of 
time in which progesterone is exceedingly high (later in the luteal phase) could result in 
compromised follicles that could ultimately lead to an increase in embryonic loss, which 
could explain the reduced prolificacy observed in ewes treated later in the estrous cycle. 
Further research needs to be conducted to elucidate the factors involved in the varied 
litter size obtained with treatment at different stages of the estrous cycle. 
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SUMMARY 
 
Through estrous synchronization, producers can optimize flock productivity and 
profitability by reducing the time and cost associated with lambing and producing a more 
uniform lamb crop that can be strategically targeted to specific markets.  Effective estrous 
synchronization methods must be economical and result in sufficiently high fertility at the 
synchronized estrus.  While traditional approaches using short-term progestogen 
treatments included application of PGF2α, the present study sought to evaluate if its 
concomitant use was required for synchronization of estrus, and if the time of PGF2α 
application relative to progesterone pre-treatment or at different predicted stages of the 
estrous cycle affects ewe fertility. 
Data were analyzed using analysis of variance and least squares means were 
calculated.  In experiment 1, progesterone-treated ewes had a higher estrous response 
than ewes receiving PGF2α only.  Ewes receiving a 5 day CIDR alone had a higher 
pregnancy rate to 1st service than ewes in other treatment groups, and a greater proportion 
of progesterone-treated ewes lambed to first service than ewes receiving PGF2α only.  
Overall, no improvements in fertility were observed in ewes receiving both progesterone 
and PGF2α at either timepoint over ewes receiving progesterone alone.  In experiment 2, 
no difference in estrous response was observed between ewes given a luteolytic dose of 
PGF2α at different predicted days of the estrous cycle, although ewes treated earlier 
(predicted day 5) had a higher conception rate than ewes treated at day 8 or 11.  Ewes 
treated at predicted day 5 also tended to have a higher pregnancy rate to first service, had 
	   	   	   53	  
a greater percentage of ewes lambing to first service, and had a higher 1st service 
prolificacy than other ewes.  These results indicate that 1) PGF2α provides no 
improvement in reproductive outcome when given as part of a progesterone- PGF2α 
estrous synchronization protocol above treatment with short-term progesterone use alone, 
and 2) reproductive outcome varies with the day of the estrous cycle on which luteolysis 
in induced, with higher conception rates and prolificacy associated with induced 
luteolysis early in the cycle.  However, further experiments are needed to elucidate the 
factors involved in the reproductive differences observed with treatment at different 
stages of the estrous cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   	   54	  
LITERATURE CITED 
 
Abecia, J. A., Forcada, F., and Gonzalez-Bulnes, A. "Hormonal Control of Reproduction 
in Small Ruminants." Animal Reproduction Science 130 (2012): 173-79. 
Abecia, J. A., Forcada, F., and Gonzalez-Bulnes, A. "Pharmaceutical Control of 
Reproduction in Sheep and Goats." Veterinary Clinics of North America: Food 
Animal Practice 27 (2011): 67-79. 
Acritopoulou, S., Haresign, W., Foster, J.P., et al.  “Plasma progesterone and LH 
concentrations in ewes after injection of an analogue of prostaglandin F-2α.”  
Journal of Reproduction and Fertility 49 (1977): 337-340. 
Acritopoulou, S., Haresign, W., Lamming, G.E.  “Time of ovulation after treatment with 
a prostaglandin F-2α analogue.”  Journal of Reproduction and Fertility 54 (1978): 
189-191. 
Acritopoulou, S., Haresign, W.  “Response of ewes to a single injection of an analogue of 
PGF-2 alpha given at different stages of the oestrous cycle.”  Journal of 
Reproduction and Fertility 58 (1980): 219-221. 
Ainsworth, L., Downey, B.R.  “A controlled internal drug-release dispenser containing 
progesterone for control of the estrous cycle of ewes.”  Theriogenology 26 (1986): 
847-856. 
Allison, A.J. and Robinson, T.J.  “The effect of dose level of intravaginal progestogen on 
sperm transport, fertilization and lambing in the cyclic merino ewe.”  Journal of 
Reproduction and Fertility 22 (1970): 515-531. 
	   	   	   55	  
Allison, A.J., Kelly R.W.  “Synchronization of oestrus and fertility in sheep treated with 
progestagen-impregnated implants, and prostaglandins with or without 
intravaginal sponges and subcutaneous pregnant mare’s serum.”  New Zealand 
Journal of Agricultural Research 21 (1978): 389-393. 
Amiridis, G.S., Cseh, S.  “Assisted reproductive technologies in the reproductive 
management of small ruminants.”  Animal Reproduction Science 130 (2012): 152-
161. 
Baird, D.T., Land, R.B, Scaramuzzi, R.J., et al.  “Endocrine changes associated with 
luteal regression in the ewe; the secretion of ovarian oestradiol, progesterone and 
androstenedione and uterine prostaglandin F2α throughout the oestrous cycle.”  
Journal of Endocrinology 69 (1976): 276-285. 
Barrett, D.M.W, Bartlewski, P.M., Cook, S.J.  “Ultrasound and endocrine evaluation of 
the ovarian response to PGF2α given at different stages of the luteal phase in 
ewes.”  Theriogenology 58 (2002): 1409-1424. 
Barrett, S., De Blockley, M.A., Cumming, et al.  “Initiation of the oestrous cycle in the 
ewe by infusions of PGF2α to the autotransplanted ovary.”  Journal of 
Reproduction and Fertility 24 (1971): 136-137. 
Bartlewski, P.M., Baby, T. E., Giffin, J.L.  “Reproductive cycles in sheep.”  Animal 
Reproduction Science 124 (2011): 259-268. 
Bartlewski, P.M., Beard, A.P, Cook, S.J.  “Ovarian antral follicular dynamics and their 
relationships with endocrine variables throughout the oestrous cycle in breeds of 
sheep differing in prolificacy.”  Journal of Reproduction and Fertility 115 (1999): 
111-124. 
	   	   	   56	  
Beal, W.E.  “A note on synchronization of oestrus in post-partum cows with 
prostaglandin F2α and a progesterone-releasing device.”  Animal Production 37 
(1983): 305-308. 
Beck, N.F.G., Davies, M.C.G., Davies, B., et al.  “Oestrus synchronization and fertility in 
ewes: a comparison of three methods.”  Animal Production 44 (1987): 251-254. 
Beck, N.F.G, Davies, B., Williams, S.P.  “Oestrous synchronization in ewes: the effect of 
combining a prostaglandin analogue with a 5-day progestagen treatment.”  Animal 
Production 56 (1993): 207-210. 
Boland, M.P., Gordon, I.R., Kelleher, D.L.  “The effect of treatment by prostaglandin 
analogue (ICI-80996) or progestagen (SC-9880) on ovulation and fertilization in 
cyclic ewes.”  Journal of Agricultural Science 91 (1978): 727-730. 
Brand, A. and de Jong, W.H.R.  “Qualitative and quantitative micromorphological 
investigations of the tertiary follicle population during the oestrous cycle in 
sheep.”  Journal of Reproduction and Fertility 33 (1973): 431-439. 
Campbell, B.K., Scaramuzzi, R.J., Webb, R.  “Control of antral follicle development and 
selection in sheep and cattle.”  Journal of Reproduction and Fertility 49 (1995): 
335-350. 
Caldwell, B.V., Tillson, S.A., Brock, W.A., et al.  “The effects of exogenous 
progesterone and estradiol on prostaglandin F levels in ovariectomized ewes.”  
Prostaglandins 1 (1972): 217-228. 
Carlson, K.M., Pohl, H.A., Marcek, J.M., et al.  “Evaluation of progesterone controlled 
internal drug release dispensers for synchronization of estrus in sheep.”  Animal 
Reproduction Science 18 (1989): 205-218. 
	   	   	   57	  
Chamley, W.A., Buckmaster, J.M., Cain, M.D., et al.  “The effect of prostaglandin F2α on 
progesterone, oestradiol and luteinizing hormone secretion in sheep with ovarian 
transplants.”  Journal of Endocrinology 55 (1972): 253-263. 
Contreras-Solis, I., Vasquez, B., Diaz, T., et al.  “Ovarian and endocrine responses in 
tropical sheep treated with reduced doses of cloprostenol.”  Animal Reproduction 
Science 114 (2009): 384-392. 
Cordeel, J.M., Leboeuf, B., Baril, G.  “Artificial breeding of adult goats and kids induced 
with hormones to ovulate outside the breeding season.”  Small Ruminant 
Research 1 (1988): 19-35. 
Davies, K.L., Bartlewski, P.M., Epp, T.  “Does injection of prostaglandin F2α (PGF2α) 
cause ovulation in anestrous Western White Face ewes?”  Theriogenology 66 
(2006) 251-259. 
Davis, A.J., Fleet, I.R., Harrison, F.A., et al.  “Pulmonary metabolism of prostaglandin 
F2α in the conscious non-pregnant ewe and sow.”  The Journal of Physiology 301 
(1980): 86. 
Deaver, D.R., Stilley, N.J., Dailey, R.A.  “Concentrations of ovarian and pituitary 
hormones following prostaglandin F2α-induced luteal regression in ewes varies 
with day of the estrous cycle at treatment.”  Journal of Animal Science 62 (1986): 
422-427. 
Dixon, I.W., Thwaites, C.J.  “The effects of single injections of progesterone on oestrous 
cycle length in ewes.”  Journal of Agricultural Science 80 (1973): 525-527. 
Douglas, R.J., Ginther, O.J.  “Luteolysis following a single injection of PGF2α in sheep.”  
Journal of Animal Science 37 (1973): 990-993. 
	   	   	   58	  
Dutt, R.H., Casida, L.E., “Alteration of the estrual cycle in sheep by use of progesterone 
and its effects upon subsequent ovulation and fertility.”  Endocrinology 43 
(1948): 208-217. 
Ensor, C.M., Tai, H.H.  “15-Hydroxyprostastaglandin dehydrogenase.”  Journal of Lipid 
Mediators and Cell Signaling 12 (1995): 313-319. 
Evans, A.C.O., Duffy, P., Hynes, N. et al.  “Waves of follicle development during the 
estrous cycle in sheep.”  Theriogenology 53 (2000): 699-715. 
Evans, A.C.O., Flynn, J.D., Quinn, K.M., et al.  “Ovulation of aged follicles does not 
affect embryo quality or fertility after a 14-day progestagen estrus 
synchronization protocol in ewes.”  Theriogenology 56 (2001): 923-936. 
Fierro, S., Olivera-Muzante, J., Gil, J.  “Effects of prostaglandin administration on 
ovarian follicular dynamics, conception, prolificacy, and fecundity in sheep.”  
Theriogenology 76 (2011): 630-639. 
Fierro, S., Gil, J., Vinoles, C.  “The use of prostaglandins in controlling the estrous cycle 
of the ewe: a review.”  Theriogenology 79 (2013): 399-408. 
Fitzgerald, J.A., Ruggles, A.J., Stellflug, J.N.  “A seven-day synchronization method for 
ewes using medroxyprogesterone acetate (MAP) and prostaglandin F2α.”  Journal 
of Animal Science 61 (1985): 466-469. 
Foster, D.L. and Karsch, F.J.  “Inhibition of tonic secretion of luteinizing hormone by 
progesterone in immature female sheep.”  Endocrinology 99 (1976): 1-6. 
Fukui, Y. and Roberts, E.M.  “Relationship between doses of prostaglandin F2α and 
stages of the breeding season for synchronization of estrus and ovulation in 
ewes.”  Theriogenology 16 (1981): 105-117. 
	   	   	   59	  
Gengenbach, D.R., Hixon, J.E., Hansel, W.  “A luteolytic interaction between estradiol 
and prostaglandin F2α in hysterectomized ewes.”  16 (1977): 571-579. 
Ginther, O.J.  “Length of estrous cycle and size or corpus luteum in guinea pigs and 
sheep treated with progesterone at different days of the estrous cycle.”  American 
Journal of Veterinary Research 30 (1969): 1975-1978. 
Ginther, O.J.  “Influence of exogenous progesterone and the uterus on ovarian activity in 
sheep.”  Endocrinology 83 (1968): 613-615. 
Ginther, O.J., Kot, K., Wiltbank, M.C.  “Association between emergence of follicular 
waves and fluctuation in FSH concentrations during the estrous cycle in ewes.”  
Theriogenology 43 (1995): 689-703. 
Gonzalez-Bulnes, A., Viega-Lopez, A., Garcia, P.  “Effects of progestagens and 
prostaglandin analogues on ovarian function and embryo viability in sheep.”  
Theriogenology 63 (2005): 2523-2534. 
Gonzalez-Bulnes, A., Souza, C.J., Campbell, B.K.  “Systemic and intraovarian effects of 
dominant follicles on ovine follicular growth.”  Animal Reproduction Science 84 
(2004): 107-119. 
Gordon, I.  “The use of progestogens in sheep bred by natural and artificial 
insemination.”  Annales De Biologie Animale, Biochimie, Biophysique 15 (1975): 
303. 
Gordon, I.  1977.  “Application of synchronization of estrus and ovulation in sheep.”  
Proceedings of the Symposium on Management and Reproduction in Sheep and 
Goats.  Pp. 15-30. Madison, WI. 
	   	   	   60	  
Greyling, J.P.C., Brink, W.C.J.  “Synchronization of oestrus in sheep: the use of 
controlled internal drug release (CIDR) dispensers.”  South African Journal of 
Animal Science 3 (1987): 128-132. 
Greyling, J.P.C., Van der Westhuysen, J.M., Van Niekerk, C.H.  “The synchronization of 
oestrus in sheep. 1. Dosage and time of prostaglandin administration following 
progestagen pretreatment.”  South African Journal of Animal Science 9 
(1979):185-192. 
Griffeth, R.J., Nett, T.M., Burns, P.P.  “Is luteal production of PGF2α necessary for 
luteolysis?”  Biology of Reproduction 66 (2002): 287 (Suppl. 1). 
Hackett, A.J., Robertson, H.A.  “Effect of dose and time of injection of prostaglandin 
PGF2α in cycling ewes.”  Theriogenology 13 (1980): 347-351. 
Hackett, A.J., Lanford, G.A., Robertson, J.A.  “Fertility of ewes after synchronization of 
oestrus with prostaglandin F2α and artificial insemination.”  Theriogenology 15 
(1981): 599-603. 
Hackett, A.J., Robertson, H.A., Wolynetz, M.S.  “Effect of prostaglandin F2α and 
pregnant mares’ serum gonadotropin (PMSG) on the reproductive performance of 
fluorogestone acetate-PMSG-treated ewes.”  Journal of Animal Science 53 
(1981): 154. 
Hamra, A.H., Massri, Y.G., Marcek, J.M.  “Plasma progesterone levels in ewes treated 
with progesterone-controlled internal drug-release dispensers, implants and 
sponges.”  Animal Reproduction Science 11 (1986): 187-194. 
Hansen, H.  “15-hydroxyprostaglandin dehydrogenase. A review.”  Prostaglandins 12 
(1974): 647-679. 
	   	   	   61	  
Haresign, W.  “Comparison of the rate of decline in plasma progesterone concentrations 
at a natural and progesterone-synchronized oestrus and its effect on tonic LH 
secretion in the ewe.”  Journal of Reproduction and Fertility 75 (1985): 231-236. 
Hawk, H.W., Conley, H.H.  “Sperm transport in ewes administered synthetic 
progestagen.”  Journal of Animal Science 33 (1971): 255-256. 
Hawk, H.W., Cooper, B.S.  “Sperm transport into the cervix of the ewe after regulation of 
estrus with prostaglandin or progestogen.”  Journal of Animal Science 44 (1977): 
638-644. 
Henderson, D.C., Downing, J.M., Beck, N.F.G.  “Oestrus synchronization in ewes: a 
comparison of prostaglandin F2α tham salt with a progestagen pessary.”  Animal 
Production 39 (1984): 229. 
Homanics, G.E., Silvia, W.J.  “Effects of progesterone and estradiol-17β on uterine 
secretion of prostaglandin F2α in response to oxytocin in ovariectomized ewes.”  
Biology of Reproduction 38 (1988): 804-811. 
Houghton, J.A., Liberati, N., Schrick, F.N.  “Day of estrous cycle affects follicular 
dynamics after induced luteolysis in ewes.”  Journal of Animal Science 73 (1995): 
2094-101. 
Inskeep, E.K.  “Estrous Cycle: Cattle, Sheep, Goat.”  Encyclopedia of Animal Science. 
New York: Marcel Dekker, 2005. Print. 
Johnson, S.K., Dailey, R.A., Inskeep, E.K.  “Effect of peripheral concentrations of 
progesterone on follicular growth and fertility in ewes.”  Domestic Animal 
Endocrinology 13 (1996): 69-79. 
	   	   	   62	  
Karsch, F.J., Legan, S. J., Hauger, R. L., et al.  “Negative feedback action of progesterone 
on tonic luteinizing hormone secretion in the ewe: dependence on the ovaries.”  
Endocrinology 101 (1977): 800-806. 
Karsch, F.J., Dahl, G. E., Evans, N.P., et al.  “Seasonal changes in gonadotropin-releasing 
hormone secretion in the ewe:  alteration in response to the negative feedback 
action of estradiol.”  Biology of Reproduction 49 (1993): 1377-1383. 
Kincl, F.A.  “Chemistry and biochemistry of progesterone.”  In: M. Tausk (Editor), 
Pharmacology of the Endocrine System and Related Drugs: Progesterone, 
Progestational Drugs and Antifertility Agents.  Pergamon Press, New York, NY, 
pp. 13-64. 
Knights, M., A. West Virginia, et al. (2003). Reproductive Management in the Ewe Flock 
by Induction Or Synchronization of Estrus, West Virginia University, Davis 
College of Agriculture, Forestry and Consumer Sciences, WV Agricultural and 
Forestry Experiment Station.  
Kruip, T.A.M. and Brand, A.  “Follicular growth during the normal cycle and after 
treatment with progestogens in the ewe.”  Ann. Biol. Anim. Biochim. Biophys. 15 
(1975): 191. 
Kusina, N.T., Tarwirei, F., Hamudikuwanda, H.  “A comparison of the effects of 
progesterone sponges and ear implants, PGF2α, and their combination on efficacy 
of estrus synchronization and fertility of Mashona goat does.”  Theriogenology 
53(2000): 1567-1580. 
	   	   	   63	  
Letelier, C.A., Contreras-Solis, I., Garcia-Fernandez, R.A., et al.  “Effects of oestrus 
induction with progestogens or prostaglandin analogues on ovarian and pituitary 
function in sheep.”  Animal Reproduction Science 126 (2011): 61-69. 
Lewis, P.E., Kiesling, D.O., Warren, J.E.  “Indomethacin inhibits progesterone-induced 
luteolysis in ewes.”  (1977) ASAS Abstracts, 69th Annual Meeting. p. 183. 
Lewis, P.E., Taylor, W.C., Inskeep, E.K.  “Exogenous progesterone on ovine corpora 
lutea.”  Journal of Animal Science 27 (1968): 1193 (Abstract). 
Leyva, V., Buckrell, B.C., Walton, J.S.  “Regulation of follicular activity and ovulation in 
ewes by exogenous progesterone.”  Theriogenology 50 (1998): 395-416. 
Light, J.E., Silvia, W.J., Reid, R.C.  “Luteolytic effect of prostaglandin F2 alpha and two 
metabolites in ewes.”  Journal of Animal Science 72 (1994): 2718-2721. 
Liu, X., Dai, Q., Hart, E., et al.  “Ovarian and endocrine responses to prostaglandin F2α 
(PGF2α) given at the expected time of the endogenous FSH peak at mid-cycle in 
ewes.”  Theriogenology 66 (2006): 811-821. 
Loubser, P.G., VanNiekerk, C.H.  “Oestrus synchronization in sheep with progesterone-
impregnated (MAP) intravaginal sponges and a prostaglandin analogue.”  
Theriogenology 15 (1981): 547. 
Louis, T.M., Parry, D.M., Robinson, J.S.  “Effects of exogenous progesterone and 
oestradiol on prostaglandin F and 13,14-dihydro-15-oxo prostaglandin F2α 
concentrations in uteri and plasma of ovariectomized ewes.”  Journal of 
Endocrinology 73 (1977): 427-439. 
Malpaux, B., Viguie, C., Skinner, D.C, et al.  “Seasonal breeding in sheep:  Mechanism 
of action of melatonin.”  Animal Reproduction Science 42 (1996): 109-117. 
	   	   	   64	  
Mann, G.E., Payne, J.H., Lamming, G.E.  “Hormonal regulation of oxytocin-induced 
prostaglandin F2α secretion by the bovine and ovine uterus in vivo.”  Domestic 
Animal Endocrinology 21 (2001): 127-141. 
McCracken, J.A., Carlson, J.C., Glew, M.E.  “Prostaglandin F2α identified as a luteolytic 
hormone in sheep.”  Nature New Biology 238 (1972): 129-134. 
McLeod, B.J, W. Haresign.  “Evidence that progesterone may influence subsequent luteal 
function in the ewe by modulating preovulatory follicle development.”  Journal of 
Reproduction and Fertility 71 (1984): 381-386. 
Meikle, A., Sahlin, L., Ferraris, A., et al.  “Endometrial mRNA expression of oestrogen 
receptor α, progesterone receptor and insulin-like growth factor-1 (IGF-1) 
throughout the bovine oestrous cycle.”  Animal Reproduction Science 68 (2001): 
45-56. 
Menchaca, A., Miller, V., Gil, J.  “Prostaglandin F2α treatment associated with timed 
artificial insemination in ewes.”  Reproduction in Domestic Animals 39 (2004): 
352-355. 
Noel, B., Bister, J.L., Pierquin, B., et al.  “Effects of FGA and PMSG on follicular 
growth and LH secretion in Suffolk ewes.”  Theriogenology 41 (1994): 719-727. 
Olivera-Muzante, J., Fierro, S., Lopez, V.  “Comparison of prostaglandin- and 
progesterone-based protocols for timed artificial insemination in sheep.”  
Theriogenology 75 (2011): 1232-1238. 
O’Mary, C.C., Pope, A.L., Casida, L.E.  “Effect on their subsequent lambing records of 
the estrual periods in a group of ewes and the use of progesterone in the 
synchronization.”  Journal of Animal Science 9 (1950): 499-503. 
	   	   	   65	  
Ottobre, J.S., Lewis, G.S., Thayne, W.V.  “Mechanism by which progesterone shortens 
the estrous cycle of the ewe.”  Biology of Reproduction 23 (1980): 1046-1053. 
Ozturkler, Y., Colak, A., Baykal, A.  “Combined effect of a prostaglandin analogue and a 
progestagen treatment for 5 days on oestrus synchronization in Tushin ewes.”  
Indian Veterinary Journal 80 (2003): 917-920.  
Paul, C.D., K.N. D’Souza, S.L. Simpson-Rastle, A.K. Redhead, and M. Knights (2014).  
Effect of Prostaglandin F2α on Fertility of Ewes Treated with a Short Term 
Progesterone-Based Estrous Synchronization Protocol.  Joint Annual Meeting of 
the ADSA/ASAS Kansas City, MO, USA, July 20-24, 2014.  Journal of Animal 
Science.  92: (Suppl. 2): 933. 
Piper, P.J., Vane, J.R., Wyllie, J.H.  “Inactivation of prostaglandins by the lungs.”  
Nature 225 (1970): 600-604. 
Pope, W.F., Cardenas, H.  “Sensitivity of sheep to exogenous prostaglandin F2α early in 
the estrous cycle.”  Small Ruminant Research 55 (2004): 245-248. 
Raw, P.E., Curry, T.E., Silvia, W.J.  “Effect of progesterone and estradiol on the 
concentration, and activity of cyclooxygenase in the ovine uterus.”  Biology of 
Reproduction (1988); Suppl. 38: 104 (abstract). 
Raw, R.E., Silvia, W.J.  “Activity of phospholipase C, and release of prostaglandin F2α by 
endometrial tissue from ovariectomized ewes receiving progesterone and 
estradiol.”  Biology of Reproduction 44 (1991): 404-414. 
Robinson, T.J.  “Fertility following synchronization of oestrus in the sheep with 
intravaginal sponges.  I.  Effects of vaginal douche, supplementary steroids, time 
	   	   	   66	  
of insemination, and numbers and dilution of spermatozoa.”  Australian Journal 
of Agricultural Research 21 (1970): 767-781. 
Robinson, T.J.  “Synchronization of oestrus in sheep by intra-vaginal and subcutaneous 
application of progestin impregnated sponges.”  Australian Society of Animal 
Production 8 (1964): 47-49. 
Robinson, T.J.  “Use of progestagen-impregnated sponges inserted intravaginally or 
subcutaneously for the control of the oestrous cycle in sheep.”  Nature 206 
(1965): 39-41. 
Robinson, T.J., Quinlivan, T.D., and Baxter, C.  “The relationship between dose of 
progestogen and method of preparation of intravaginal sponges on their 
effectiveness for the control of ovulation in the ewe.”  Journal of Reproduction 
and Fertility 17 (1968): 471. 
Rosa, H.J.D, Bryant, M.J. “Seasonality of reproduction in sheep.”  Small Ruminant 
Research 48 (2003): 155-171. 
Rubianes, E., Menchaca, A., Carbajal, B.  “Response of the 1-5 day-aged ovine corpus 
luteum to prostaglandin F2α.”  Animal Reproduction Science 78 (2003): 47-55. 
Rubianes, E., Beard, A., Dierschke, D., et al.  “Endocrine and ultrasound evaluation of 
the response to PGF2α and GnRH given at different stages of the luteal phase in 
cycling ewes.”  Theriogenology 48 (1997): 1093-1104. 
Ruiz-Gonzalez, I., Sanchez, M.A., Garcia-Fernandez, R.A., et al.  “Different influence of 
ovine estrus synchronization treatments on caruncular early angiogenesis.”  
Histology and Histopathology 28 (2013): 373-383. 
	   	   	   67	  
Salamonson, L.A., Hampton, A.L., Clements, J.A., et al.  “Regulation of gene expression, 
and cellular localization of prostaglandin synthase by oestrogen, and progesterone 
in the ovine uterus.”  Journal of Reproduction & Fertility 92 (1991): 393-406. 
Scaramuzzi, R.J., Downing, J.A., Campbell, B.K., et al.  “Control of fertility and 
fecundity of sheep by means of hormonal manipulation.”  Australian Journal of 
Biological Sciences 41 (1988): 37-45. 
Scaramuzzi, R.J., Lindsay, D.R., Shelton, J.  “Effect of repeated oestrogen administration 
on oestrus behavior in ovariectomized ewes.”  Journal of Endocrinology 52 
(1972): 269-278. 
Scaramuzzi, R.J., Baird, D.T., Boyle, H.P., et al.  “The secretion of prostaglandin F from 
the autotransplanted uterus of the ewe.”  Journal of Reproduction and Fertility 49 
(1977): 157-160. 
Scaramuzzi, R.J., Martin, G.B. "Pharmacological Agents for Manipulating Oestrus and 
Ovulation in the Ewe." Reproduction in Sheep. Canberra: Australian Academy of 
Science, 1984. 316-25. Print. 
Schoombee, C.J.A.  “The effect of prostaglandin PGF2α when administered at different 
stages during the oestrus cycle.”  Acricola (Namibia) (1996) 
Senger, P.L.  Pathways to Pregnancy & Parturition. 3rd ed. Redmon, OR: Current 
Conceptions, 2012. Print. 
Shrick, F.N., Surface, R.A., Pritchard, J.Y., et al.  “Ovarian structures during the estrous 
cycle and early pregnancy in ewes.”  Biology of Reproduction 49 (1993): 1133-
1140. 
	   	   	   68	  
Silva, P.J., Juengel, J.L., Rollyson, M.K.  “Prostaglandin metabolism in the ovine corpus 
luteum: catabolism of prostaglandin F2α coincides with resistance of the corpus 
luteum to PGF2α.”  Biology of Reproduction 63 (2000): 1229-1236. 
Silvia, W.J., Lewis, G.S., McCracken, J.A.  “Hormonal regulation of uterine secretion of 
prostaglandin F2α during luteolysis in ruminants.”  Biology of Reproduction 45 
(1991): 655-663. 
Simonetti, L., Blanco, M.R., Gardon, J.C.  “Estrus synchronization in ewes treated with 
sponges impregnated with different doses of medroxyprogesterone acetate.”  
Small Ruminant Research 38 (2000): 243-247. 
Smith, R.D., Pomerantz, A.J., Beal, W.E.  “Insemination of Holstein heifers at a preset 
time after estrous cycle synchronization using progesterone and prostaglandin.”  
Journal of Animal Science 58 (1984): 792. 
Sosa, C., Abecia, J.A., Forcada, F., et al.  “Undernutrition reduces the oviductal 
mRNAexpression of progesterone and oestrogen receptors in sheep.”  The 
Veterinary Journal 175 (2008): 413-415. 
Thwaites, C.J.  “Exogenous progesterone and oestrous cycle length in the ewe.”  Journal 
of Agricultural Science 77 (1971): 147-149. 
Trounson, A.O., Willadsen, S.M., Moor, R.M.  “Effect of prostaglandin analog 
cloprostenol on estrus, ovulation and embryonic viability in sheep.”  Journal of 
Agricultural Science, Cambridge 86 (1976): 609-611. 
Tsai, S.J., Wiltbank, M.C.  “Prostaglandin F2α induces expression of prostaglandin G/H 
synthase-2 in the ovine corpus luteum: a potential positive feedback loop during 
luteolysis.”  Biology of Reproduction 57 (1997): 1016-1022. 
	   	   	   69	  
Vallet, J.L., Lamming, G.E., Batten, M.  “Control of endometrial oxytocin receptor, and 
uterine response to oxytocin by progesterone, and oestradiol.”  Journal of 
Reproduction & Fertility 90 (1990): 625-634. 
Vincent, D.L., Inskeep, E.K.  “Role of progesterone in regulating uteroovarian venous 
concentrations of PGF2α and PGE2 during the estrous cycle and early pregnancy 
in ewes.”  Prostaglandins 31 (1986): 715-733. 
Vinoles, C., Forsberg, M., Banchero, G.  “Effect of long-term and short-term progestagen 
treatment on follicular development and pregnancy rate in cyclic ewes.”  
Theriogenology 55 (2001): 993-1004. 
Vinoles, C., Rubianes, E.  “Origin of the preovulatory follicle after induced luteolysis 
during the early luteal phase in ewes.”  Canadian Journal of Animal Science 78 
(1998): 429-431. 
Vinoles, C., Meikle, A., Forsberg, M.  “The effect of subluteal levels of exogenous 
progesterone on follicular dynamics and endocrine patterns during the early luteal 
phase in the ewe.”  Theriogenology 51 (1999): 1351-1361. 
Weems, C.W., Weems, Y.S., Randel, R.D.  “Prostaglandins and reproduction in female 
farm animals.”  The Veterinary Journal 171 (2006): 206-228. 
Welch, R.A.S., Andrewes, W.D., Barnes, D.R.  “CIDR dispensers for oestrus and 
ovulation control in sheep.  In: Proceedings of the 10th International Contress on 
Animal Reproduction & Artificial Insemination, vol. 3. Urbana (IL); 1984. P. 
354-355. 
	   	   	   70	  
Wheaton, J.E., Carlson, K.M., Windels, H.F.  “CIDR: a new progesterone-releasing 
intravaginal device for induction of estrus and cycle control in sheep and goats.”  
Animal Reproduction Science 33 (1993): 127-141. 
White, L.M., Keisler, D.H., Dailey, R.A., et al.  “Characterization of ovine follicles 
destined to form subfunctional corpora lutea.”  Journal of Animal Science 65 
(1987): 1595-1601. 
Wiley, T.M., Cardenas, H., Pope, W.F.  “Effect of the rate of progesterone decline at 
luteolysis on the ovulatory follicles and subsequent estrous cycle length in ewes.”  
Animal Reproduction Science 46 (1997): 79-87. 
Wiltbank, M.C., Ottobre, J.S.  “Regulation of intraluteal production of prostaglandins.”  
Reproductive Biology and Endocrinology 91 (2003). 
Woody, C.O., First, N.L., Pope, A.L.  “Effect of exogenous progesterone on estrous cycle 
length.”  Journal of Animal Science 26 (1967a): 139. 
Woody, C.O., Ginther, O.J., Pope, A.L.  “Effects of exogenous progesterone and 
hysterectomy on corpora lutea in ewes.”  Journal of Animal Science 27 (1968): 
1383-1386. 
Zimbelman, R.G., Pope, A.L., Casida, L.E.  “Effect of exogenous progesterone on the 
corpus luteum of the bred ewe.”  Journal of Animal Science 18 (1959): 1327-
1332. 
 
 
 
 
	   	   	   71	  
VITA 
 
Callayn Danae Paul 
 
Birthplace……………………………………………………………....………Wabash, IN 
Date of Birth……………………………………………………………..…June 22, 1989 
Schools Attended: 
 Southwood Elementary School…………………………..……………..1995-2002 
 Wabash, IN 
 Southwood Jr./Sr. High School…………………………………..……..2002-2008 
 Wabash, IN 
 The University of Findlay……………………………...………………..2008-2013 
 Findlay, OH 
 West Virginia University……………………………….………….……2013-2015 
 Morgantown, WV 
Degrees Received: 
 Bachelor of Science in Pre-Veterinary Medicine, Equestrian Studies, and Biology 
  The University of Findlay, 2013 
 Master of Science in Animal Physiology 
  West Virginia University, 2015 
 	  
